- ICH GCP
- Реестр клинических исследований США
- Клиническое испытание NCT00412984
Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation (ARISTOTLE)
5 июня 2018 г. обновлено: Bristol-Myers Squibb
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation
The trial seeks to determine if apixaban, an investigational anticoagulant (blood-thinner) is as effective as standard therapy (warfarin) in preventing stroke and systemic embolism in subjects with atrial fibrillation and risk factors for stroke.
Обзор исследования
Статус
Завершенный
Вмешательство/лечение
Тип исследования
Интервенционный
Регистрация (Действительный)
20976
Фаза
- Фаза 3
Контакты и местонахождение
В этом разделе приведены контактные данные лиц, проводящих исследование, и информация о том, где проводится это исследование.
Места учебы
-
-
New South Wales
-
Coffs Harbour, New South Wales, Австралия, 2450
- Local Institution
-
Concord, New South Wales, Австралия, 2139
- Local Institution
-
Gosford, New South Wales, Австралия, 2250
- Local Institution
-
Kogarah, New South Wales, Австралия, 2217
- Local Institution
-
Miranda, New South Wales, Австралия, 2228
- Local Institution
-
-
Queensland
-
Auchenflower, Queensland, Австралия, 4066
- Local Institution
-
Brisbane, Queensland, Австралия, 4032
- Local Institution
-
Caboolture, Queensland, Австралия, 4510
- Local Institution
-
Herston, Queensland, Австралия, 4029
- Local Institution
-
Kippa Ring, Queensland, Австралия, 4021
- Local Institution
-
Nambour, Queensland, Австралия, 4560
- Local Institution
-
Sherwood, Queensland, Австралия, 4075
- Local Institution
-
-
South Australia
-
Adelaide, South Australia, Австралия, SA 5000
- Local Institution
-
Ashford, South Australia, Австралия, 5035
- Local Institution
-
Bedford Park, South Australia, Австралия, 5042
- Local Institution
-
Woodville, South Australia, Австралия, 5011
- Local Institution
-
-
Victoria
-
Box Hill, Victoria, Австралия, 3128
- Local Institution
-
Dandenong, Victoria, Австралия, 3175
- Local Institution
-
Geelong, Victoria, Австралия, 3220
- Local Institution
-
-
Western Australia
-
Fremantle, Western Australia, Австралия, 6160
- Local Institution
-
Joondalup, Western Australia, Австралия, 6027
- Local Institution
-
-
-
-
-
Graz, Австрия, 8036
- Local Institution
-
Oberpullendorf, Австрия, 7350
- Local Institution
-
Vienna, Австрия, 1160
- Local Institution
-
-
-
-
-
Buenos Aires, Аргентина, 1119
- Local Institution
-
Buenos Aires, Аргентина, C1280AEB
- Local Institution
-
Buenos Aires, Аргентина, 1181
- Local Institution
-
Buenos Aires, Аргентина, C1426ANZ
- Local Institution
-
Buenos Aires, Аргентина, 1280
- Local Institution
-
Cordoba, Аргентина, 5000
- Local Institution
-
Cordoba, Аргентина, X5000EPU
- Local Institution
-
Cordoba, Аргентина, X5008KKF
- Local Institution
-
Cordoba, Аргентина, X5003DCE
- Local Institution
-
Salta, Аргентина, 4400
- Local Institution
-
Santa Fe, Аргентина, 3000
- Local Institution
-
Tucuman, Аргентина, T4000NIL
- Local Institution
-
-
Buenos Aires
-
Adrogue, Buenos Aires, Аргентина, 1846
- Local Institution
-
Bahia Blanca, Buenos Aires, Аргентина, B8000FTD
- Local Institution
-
Ciudad Autonoma, Buenos Aires, Аргентина, CP1425A WC
- Local Institution
-
Ciudad Autonoma, Buenos Aires, Аргентина, 1128AAD
- Local Institution
-
Ciudad Autonoma, Buenos Aires, Аргентина, 1128
- Local Institution
-
Ciudad Autonoma, Buenos Aires, Аргентина, 1426 EGR
- Local Institution
-
Ciudad Autonoma, Buenos Aires, Аргентина, C1426 EGR
- Local Institution
-
Ciudad Autonoma, Buenos Aires, Аргентина, CP1425AWC
- Local Institution
-
Ciudad Autonoma De, Buenos Aires, Аргентина, 1180
- Local Institution
-
Ciudad Autonoma De Buenos Aire, Buenos Aires, Аргентина, CI094AAD
- Local Institution
-
Coronel Suarez, Buenos Aires, Аргентина, B7540GHD
- Local Institution
-
Haedo, Buenos Aires, Аргентина, B1706AJU
- Local Institution
-
Junin, Buenos Aires, Аргентина, 6000
- Local Institution
-
La Plata, Buenos Aires, Аргентина, 1900
- Local Institution
-
La Plata, Buenos Aires, Аргентина, B1900AXI
- Local Institution
-
La Plata, Buenos Aires, Аргентина, 1902
- Local Institution
-
Mar Del Plata, Buenos Aires, Аргентина, 7600
- Local Institution
-
Merlo, Buenos Aires, Аргентина, B1722COV
- Local Institution
-
Merlo, Buenos Aires, Аргентина, 1722
- Local Institution
-
Olivos, Buenos Aires, Аргентина, 1602
- Local Institution
-
Quilmes, Buenos Aires, Аргентина, 1878
- Local Institution
-
Ramos Mejia, Buenos Aires, Аргентина, B1704ESN
- Local Institution
-
Ramos Mejia, Buenos Aires, Аргентина, B1704ETD
- Local Institution
-
Ramos Mejia, Buenos Aires, Аргентина, 1706
- Local Institution
-
San Justo, Buenos Aires, Аргентина, 1754
- Local Institution
-
San Martin, Buenos Aires, Аргентина, 1650
- Local Institution
-
San Nicolas, Buenos Aires, Аргентина, 2900
- Local Institution
-
Zarate, Buenos Aires, Аргентина, 2800
- Local Institution
-
Zarate, Buenos Aires, Аргентина, B2800DGH
- Local Institution
-
-
Provincia DE Cordoba
-
Cordoba, Provincia DE Cordoba, Аргентина, 5000
- Local Institution
-
-
RIO Negro
-
Cipolletti, RIO Negro, Аргентина, 8324
- Local Institution
-
-
Santa FE
-
Rosario, Santa FE, Аргентина, 2000
- Local Institution
-
Rosario, Santa FE, Аргентина, S2000CVB
- Local Institution
-
Rosario, Santa FE, Аргентина, S2001ODA
- Local Institution
-
-
Santa Fe
-
Rosario, Santa Fe, Аргентина, S2000CVD
- Local Institution
-
Rosario, Santa Fe, Аргентина, S2000 CVD
- Local Institution
-
-
Tucuman
-
San Miquel De Tucuman, Tucuman, Аргентина, 4000
- Local Institution
-
-
-
-
-
Aalst, Бельгия, 9300
- Local Institution
-
Antwerpen, Бельгия, 2020
- Local Institution
-
Antwerpen, Бельгия, 2060
- Local Institution
-
Arlon, Бельгия, 6700
- Local Institution
-
Brugge, Бельгия, 8000
- Local Institution
-
Brussels, Бельгия, 1090
- Local Institution
-
Dillingen, Бельгия, 66763
- Local Institution
-
Genk, Бельгия, 3600
- Local Institution
-
Gent, Бельгия, 9000
- Local Institution
-
Gilly, Бельгия, 6060
- Local Institution
-
Hasselt, Бельгия, 3500
- Local Institution
-
Huy, Бельгия, 4500
- Local Institution
-
Kortrijk, Бельгия, 8500
- Local Institution
-
Menen, Бельгия, 8930
- Local Institution
-
Mol, Бельгия, 2400
- Local Institution
-
Montegnee, Бельгия, 4420
- Local Institution
-
Verviers, Бельгия, 4800
- Local Institution
-
Woluwe- Saint Lambert, Бельгия, 1200
- Local Institution
-
Yvoir, Бельгия, 5530
- Local Institution
-
-
-
-
-
Rio De Janeiro, Бразилия, 20551
- Local Institution
-
Rio De Janeiro, Бразилия, 20551-030
- Local Institution
-
Rio De Janeiro, Бразилия, 22251-030
- Local Institution
-
Rio De Janeiro, Бразилия, 22251
- Local Institution
-
Sao Paulo, Бразилия, 01323-010
- Local Institution
-
Sao Paulo, Бразилия, 01323
- Local Institution
-
Sao Paulo, Бразилия, 04012
- Local Institution
-
Sao Paulo, Бразилия, 04024-002
- Local Institution
-
Sao Paulo, Бразилия, 04038
- Local Institution
-
Sao Paulo, Бразилия, 01221-900
- Local Institution
-
Sao Paulo, Бразилия, 01221
- Local Institution
-
Sao Paulo, Бразилия, 01322-001
- Local Institution
-
Sao Paulo, Бразилия, 01322
- Local Institution
-
Sao Paulo, Бразилия, 01323-001
- Local Institution
-
Sao Paulo, Бразилия, 04012-180
- Local Institution
-
Sao Paulo, Бразилия, 04024
- Local Institution
-
Sao Paulo, Бразилия, 04038-031
- Local Institution
-
Sao Paulo, Бразилия, 08270-070
- Local Institution
-
Sao Paulo, Бразилия, 08270
- Local Institution
-
-
Bahia
-
Salvador, Bahia, Бразилия, 40144
- Local Institution
-
Salvador, Bahia, Бразилия, 41810
- Local Institution
-
Salvador, Bahia, Бразилия, 40144-900
- Local Institution
-
Salvador, Bahia, Бразилия, 41810-010
- Local Institution
-
-
Minas Gerais
-
Belo Horzonte, Minas Gerais, Бразилия, 30150-221
- Local Institution
-
Belo Horzonte, Minas Gerais, Бразилия, 30150
- Local Institution
-
Juiz De Fora, Minas Gerais, Бразилия, 36021-630
- Local Institution
-
Juiz De Fora, Minas Gerais, Бразилия, 36021
- Local Institution
-
Uberaba, Minas Gerais, Бразилия, 38056 055
- Local Institution
-
Uberlandia, Minas Gerais, Бразилия, 38400-299
- Local Institution
-
Uberlandia, Minas Gerais, Бразилия, 38400
- Local Institution
-
-
Para
-
Belem, Para, Бразилия, 66087-660
- Local Institution
-
Belem, Para, Бразилия, 66087
- Local Institution
-
-
Parana
-
Campina Grande Do Sul, Parana, Бразилия, 83430-000
- Local Institution
-
Campina Grande Do Sul, Parana, Бразилия, 83430
- Local Institution
-
Curitiba, Parana, Бразилия, 80010
- Local Institution
-
Curitiba, Parana, Бразилия, 80730
- Local Institution
-
Curitiba, Parana, Бразилия, 80010-030
- Local Institution
-
Curitiba, Parana, Бразилия, 80730-150
- Local Institution
-
Londrina, Parana, Бразилия, 86010-450
- Local Institution
-
Londrina, Parana, Бразилия, 86010
- Local Institution
-
-
RIO Grande DO Norte
-
Natal, RIO Grande DO Norte, Бразилия, 59020-100
- Local Institution
-
-
RIO Grande DO SUL
-
Porte Alegre, RIO Grande DO SUL, Бразилия, 90610-000
- Local Institution
-
Porte Alegre, RIO Grande DO SUL, Бразилия, 90880-480
- Local Institution
-
Porto Alegre, RIO Grande DO SUL, Бразилия, 90035-903
- Local Institution
-
Porto Alegre, RIO Grande DO SUL, Бразилия, 90020-090
- Local Institution
-
Porto Alegre, RIO Grande DO SUL, Бразилия, 90620-001
- Local Institution
-
Porto Alegre, RIO Grande DO SUL, Бразилия, 91350-280
- Local Institution
-
-
Rio Grande Do Norte
-
Natal, Rio Grande Do Norte, Бразилия, 59020
- Local Institution
-
-
Rio Grande Do Sul
-
Porte Alegre, Rio Grande Do Sul, Бразилия, 90610
- Local Institution
-
Porte Alegre, Rio Grande Do Sul, Бразилия, 90880480
- Local Institution
-
Porto Alegre, Rio Grande Do Sul, Бразилия, 90035
- Local Institution
-
Porto Alegre, Rio Grande Do Sul, Бразилия, 90020
- Local Institution
-
Porto Alegre, Rio Grande Do Sul, Бразилия, 90620
- Local Institution
-
Porto Alegre, Rio Grande Do Sul, Бразилия, 91350
- Local Institution
-
-
SAO Paulo
-
Botucatu, SAO Paulo, Бразилия, 18618-000
- Local Institution
-
Campinas, SAO Paulo, Бразилия, 13059-740
- Local Institution
-
Marilia, SAO Paulo, Бразилия, 17515-000
- Local Institution
-
Marilia, SAO Paulo, Бразилия, 17515-460
- Local Institution
-
Marilia, SAO Paulo, Бразилия, 17519-000
- Local Institution
-
San Jose Do Rio Preto, SAO Paulo, Бразилия, 15090-000
- Local Institution
-
Santo Andre, SAO Paulo, Бразилия, 09190-610
- Local Institution
-
Sao Jose Do Rio Preto, SAO Paulo, Бразилия, 15015-750
- Local Institution
-
Sao Jose Do Rio Preto, SAO Paulo, Бразилия, 15015-210
- Local Institution
-
-
Santa Catarina
-
Blumenau, Santa Catarina, Бразилия, 89010
- Local Institution
-
Blumenau, Santa Catarina, Бразилия, 89010-500
- Local Institution
-
Sao Jose, Santa Catarina, Бразилия, 88103
- Local Institution
-
Sao Jose, Santa Catarina, Бразилия, 88103-450
- Local Institution
-
-
Sao Paulo
-
Botucatu, Sao Paulo, Бразилия, 18618
- Local Institution
-
Campinas, Sao Paulo, Бразилия, 13059
- Local Institution
-
Marilia, Sao Paulo, Бразилия, 17519
- Local Institution
-
Marilia, Sao Paulo, Бразилия, 17515
- Local Institution
-
San Jose Do Rio Preto, Sao Paulo, Бразилия, 15090
- Local Institution
-
Santo Andre, Sao Paulo, Бразилия, 09190
- Local Institution
-
Sao Jose Do Rio Preto, Sao Paulo, Бразилия, 15015
- Local Institution
-
-
-
-
-
Budapest, Венгрия, 1125
- Local Institution
-
Budapest, Венгрия, 1023
- Local Institution
-
Budapest, Венгрия, 1032
- Local Institution
-
Budapest, Венгрия, 1096
- Local Institution
-
Budapest, Венгрия, 1085
- Local Institution
-
Debrecen, Венгрия, 4032
- Local Institution
-
Dunaujvaros, Венгрия, 2400
- Local Institution
-
Gyor, Венгрия, 9023
- Local Institution
-
Gyula, Венгрия, 5700
- Local Institution
-
Hodmezovasarhely, Венгрия, 6800
- Local Institution
-
Komarom, Венгрия, 2921
- Local Institution
-
Mosonmagyarovar, Венгрия, 9200
- Local Institution
-
Oroshaza, Венгрия, 5900
- Local Institution
-
Pecs, Венгрия, 7624
- Local Institution
-
Siofok, Венгрия, 8600
- Local Institution
-
Siofok, Венгрия, 8601
- Local Institution
-
Sopron, Венгрия, 9400
- Local Institution
-
Szentes, Венгрия, 6600
- Local Institution
-
Zalaegerszeg, Венгрия, 8900
- Local Institution
-
-
-
-
-
Aachen, Германия, 52074
- Local Institution
-
Bad Krozingen, Германия, 79189
- Local Institution
-
Bad Neustadt/ Salle, Германия, 97616
- Local Institution
-
Bad Oeynhausen, Германия, 32545
- Local Institution
-
Berlin, Германия, 13353
- Local Institution
-
Berlin, Германия, 14050
- Local Institution
-
Berlin, Германия, 10787
- Local Institution
-
Berlin, Германия, 10789
- Local Institution
-
Berlin, Германия, 12043
- Local Institution
-
Berlin-Kopenick, Германия, 12559
- Local Institution
-
Betzdorf, Германия, 57518
- Local Institution
-
Bochum, Германия, 44791
- Local Institution
-
Bochum, Германия, 44789
- Local Institution
-
Bonn, Германия, 53127
- Local Institution
-
Coburg, Германия, 96450
- Local Institution
-
Dillingen, Германия, 66763
- Local Institution
-
Dresden, Германия, 01099
- Local Institution
-
Duisburg, Германия, 47139
- Local Institution
-
Essen, Германия, 45122
- Local Institution
-
Frankfurt Am Main, Германия, 60594
- Local Institution
-
Gottingen, Германия, 37075
- Local Institution
-
Halle/Saale, Германия, 06120
- Local Institution
-
Hannover, Германия, 30625
- Local Institution
-
Heidelberg, Германия, 69120
- Local Institution
-
Heidelberg, Германия, 69115
- Local Institution
-
Kassel, Германия, 34121
- Local Institution
-
Lahr, Германия, 77933
- Local Institution
-
Ludwigshafen, Германия, 67063
- Local Institution
-
Ludwigshafen, Германия, 67073
- Local Institution
-
Mannheim, Германия, 68167
- Local Institution
-
Marburg, Германия, 35043
- Local Institution
-
Munchen, Германия, 81675
- Local Institution
-
Munchen, Германия, 80636
- Local Institution
-
Munchen, Германия, 81545
- Local Institution
-
Osnabruck, Германия, 49076
- Local Institution
-
Regensburg, Германия, 93053
- Local Institution
-
Riesa, Германия, D-01587
- Local Institution
-
Rostiock, Германия, 18057
- Local Institution
-
Trier, Германия, 54292
- Local Institution
-
Waren, Германия, 17192
- Local Institution
-
Witten, Германия, 58455
- Local Institution
-
Wolmirstedt, Германия, 39326
- Local Institution
-
Worms, Германия, 67550
- Local Institution
-
-
-
-
-
Hong Kong, Гонконг
- Local Institution
-
Shatin, Гонконг
- Local Institution
-
-
-
-
-
Arhus C, Дания, 8000
- Local Institution
-
Esbjerg, Дания, 6700
- Local Institution
-
Frederiksberg, Дания, 2000
- Local Institution
-
Frederikssund, Дания, 3600
- Local Institution
-
Gentofte, Дания, 2900
- Local Institution
-
Haderslev, Дания, 6100
- Local Institution
-
Hellerup, Дания, 2900
- Local Institution
-
Herlev, Дания, 2730
- Local Institution
-
Herning, Дания, 7400
- Local Institution
-
Hillerod, Дания, 3400
- Local Institution
-
Hvidovre, Дания, 2650
- Local Institution
-
Kobenhavn, Дания, 2100
- Local Institution
-
Kolding, Дания, 6000
- Local Institution
-
Odense, Дания, 5000
- Local Institution
-
Silkeborg, Дания, 8600
- Local Institution
-
Slagelse, Дания, 4200
- Local Institution
-
Svendborg, Дания, 5700
- Local Institution
-
-
-
-
-
Afula, Израиль, 18101
- Local Institution
-
Ashkelon, Израиль, 78306
- Local Institution
-
Givatayim, Израиль, 53583
- Local Institution
-
Hadera, Израиль, 38100
- Local Institution
-
Haifa, Израиль, 31096
- Local Institution
-
Haifa, Израиль, 34362
- Local Institution
-
Holon, Израиль, 58100
- Local Institution
-
Jerusalem, Израиль, 91120
- Local Institution
-
Jerusalem, Израиль, 91240
- Local Institution
-
Kfar-Saba, Израиль, 44281
- Local Institution
-
Nazareth, Израиль, 16100
- Local Institution
-
Nazareth, Израиль, 16000
- Local Institution
-
Petach-Tikva, Израиль, 49100
- Local Institution
-
Safed, Израиль, 13100
- Local Institution
-
Tel Aviv, Израиль, 64239
- Local Institution
-
-
-
-
-
Ahmedabad, Индия, 380014
- Local Institution
-
Annamalainagar, Индия, 608002
- Local Institution
-
Bangalore, Индия, 560052
- Local Institution
-
Chennai, Индия, 600006
- Local Institution
-
Hyderabad, Индия, 500001
- Local Institution
-
Hyderabad, Индия, 500044
- Local Institution
-
Indore, Индия, 452014
- Local Institution
-
Indore, Индия, 452001
- Local Institution
-
Kolkata, Индия, 700054
- Local Institution
-
Kottayam, Индия, 686016
- Local Institution
-
Lucknow, Индия, 226003
- Local Institution
-
Mumbai Naka, Индия, 422005
- Local Institution
-
Nashik, Индия, 422002
- Local Institution
-
New Delhi, Индия, 110025
- Local Institution
-
New Delhi, Индия, 110060
- Local Institution
-
New Delhi, Индия, 116025
- Local Institution
-
Pune, Индия, 411001
- Local Institution
-
Pune, Индия, 411004
- Local Institution
-
Thrissur, Индия, 680002
- Local Institution
-
Vijayawada, Индия, 520008
- Local Institution
-
-
Andhra Pradesh
-
Visakhapatnam, Andhra Pradesh, Индия, 530003
- Local Institution
-
-
Andhrapradesh
-
Visakhapatnam, Andhrapradesh, Индия, 530002
- Local Institution
-
-
Andra Pradesh
-
Hyderabad, Andra Pradesh, Индия, 500004
- Local Institution
-
-
Gujarat
-
Ahmedabad, Gujarat, Индия, 380060
- Local Institution
-
Vadodara, Gujarat, Индия, 390007
- Local Institution
-
-
Karnataka
-
Bangalore, Karnataka, Индия, 560054
- Local Institution
-
Bangalore, Karnataka, Индия, 5600034
- Local Institution
-
Bangalore, Karnataka, Индия, 560094
- Local Institution
-
Mysore, Karnataka, Индия, 570004
- Local Institution
-
-
Kerela
-
Calicut, Kerela, Индия, 673 004
- Local Institution
-
-
Maharashta
-
Pune, Maharashta, Индия, 411011
- Local Institution
-
-
Maharashtra
-
Nagpur, Maharashtra, Индия, 440010
- Local Institution
-
Nagpur, Maharashtra, Индия, 440012
- Local Institution
-
Pune, Maharashtra, Индия, 411001
- Local Institution
-
Pune, Maharashtra, Индия, 421006
- Local Institution
-
-
Punjab
-
Jalandhar, Punjab, Индия, 144008
- Local Institution
-
-
Rajasthan
-
Bikaner, Rajasthan, Индия, 334001
- Local Institution
-
Bikaner, Rajasthan, Индия, 334003
- Local Institution
-
-
Uttar Pradesh
-
Lucknow, Uttar Pradesh, Индия, 226003
- Local Institution
-
-
-
-
-
Albacete, Испания, 02006
- Local Institution
-
Barcelona, Испания, 08035
- Local Institution
-
Barcelona, Испания, 08003
- Local Institution
-
Elda, Испания, 03600
- Local Institution
-
Figueres, Испания, 17600
- Local Institution
-
Gerona, Испания, 17007
- Local Institution
-
Las Palmas, Испания, 35010
- Local Institution
-
Madrid, Испания, 28006
- Local Institution
-
Madrid, Испания, 28046
- Local Institution
-
Madrid, Испания, 28040
- Local Institution
-
Palma De Mallorca, Испания, 07010
- Local Institution
-
San Sebastian De Los Reyes, Испания, 28703
- Local Institution
-
Tarragona, Испания, 43007
- Local Institution
-
Viladecans, Испания, 08840
- Local Institution
-
-
Alicante
-
San Juan, Alicante, Испания, 03550
- Local Institution
-
Torrevieja, Alicante, Испания, 03186
- Local Institution
-
-
Almeria
-
La Canada, Almeria, Испания, 04120
- Local Institution
-
-
Galicia
-
Lugo, Galicia, Испания, 27003
- Local Institution
-
-
-
-
-
Ascoli Piceno, Италия, 63100
- Local Institution
-
Campobasso, Италия, 86100
- Local Institution
-
Chieti, Италия, 66013
- Local Institution
-
Cremona, Италия, 26100
- Local Institution
-
Fidenza (Pr), Италия, 43036
- Local Institution
-
Genova, Италия, 16132
- Local Institution
-
Isernia, Италия, 86170
- Local Institution
-
Livorno, Италия, 57100
- Local Institution
-
Milano, Италия, 20132
- Local Institution
-
Napoli, Италия, 80131
- Local Institution
-
Palermo, Италия, 90127
- Local Institution
-
Reggio Emilia, Италия, 42100
- Local Institution
-
Roma, Италия, 00168
- Local Institution
-
San Daniele De Friuli, Италия, 33038
- Local Institution
-
Torino, Италия, 10153
- Local Institution
-
Vittorio Veneto (Tv), Италия, 31029
- Local Institution
-
-
Lucca
-
Lido Di Camaiore, Lucca, Италия, 55043
- Local Institution
-
-
-
-
-
Quebec, Канада, G1J 1Z6
- Local Institution
-
-
Alberta
-
Calgary, Alberta, Канада, T2E 7C5
- Local Institution
-
Edmonton, Alberta, Канада, T6G 2B7
- Local Institution
-
Edmonton, Alberta, Канада, T5X 3N5
- Local Institution
-
Edmonton, Alberta, Канада, TSA 4L8
- Local Institution
-
Edmonton, Alberta, Канада, T56-3NJ
- Local Institution
-
-
British Columbia
-
Burnaby, British Columbia, Канада, V5G 1T4
- Local Institution
-
Nanaimo, British Columbia, Канада, V9R 3G9
- Local Institution
-
New Westminster, British Columbia, Канада, V3L 3W4
- Local Institution
-
North Vancouver, British Columbia, Канада, V7N 4M2
- Local Institution
-
Victoria, British Columbia, Канада, V8R 4R2
- Local Institution
-
-
Manitoba
-
Winnipeg, Manitoba, Канада, R2V 4W3
- Local Institution
-
-
New Brunswick
-
Bathurst, New Brunswick, Канада, E2A 4X7
- Local Institution
-
-
Newfoundland and Labrador
-
Mount Pearl, Newfoundland and Labrador, Канада, A1N 1W7
- Local Institution
-
St Johns, Newfoundland and Labrador, Канада, A1B 3V6
- Local Institution
-
St. John'S, Newfoundland and Labrador, Канада, A1A 3R5
- Local Institution
-
St. John'S, Newfoundland and Labrador, Канада, A1E 2C2
- Local Institution
-
-
Ontario
-
Brampton, Ontario, Канада, L6Z 4N5
- Local Institution
-
Burlington, Ontario, Канада, L7M 4Y1
- Local Institution
-
Cambridge, Ontario, Канада, N1R 7R1
- Local Institution
-
Cambridge, Ontario, Канада, N1R 6V6
- Local Institution
-
Hamilton, Ontario, Канада, L8L 2X2
- Local Institution
-
London, Ontario, Канада, N6G 2V2
- Local Institution
-
Mississauga, Ontario, Канада, L5B 4A2
- Local Institution
-
Newmarket, Ontario, Канада, L3Y 5G8
- Local Institution
-
Newmarket, Ontario, Канада, L3Y 8C3
- Local Institution
-
Niagara Falls, Ontario, Канада, L2E 7H1
- Local Institution
-
Niagara Falls, Ontario, Канада, L2E7H1
- Local Institution
-
North Bay, Ontario, Канада, P1B 2H3
- Local Institution
-
Oshawa, Ontario, Канада, L1J 2J9
- Local Institution
-
Oshawa, Ontario, Канада, L1J 2K1
- Local Institution
-
Ottawa, Ontario, Канада, K1Y 4E9
- Local Institution
-
Ottawa, Ontario, Канада, K1Y 4W7
- Local Institution
-
Sarnia, Ontario, Канада, N7T 4X3
- Local Institution
-
Scarborough, Ontario, Канада, M1B 5N1
- Local Institution
-
Sudbury, Ontario, Канада, P3E 3B8
- Local Institution
-
Sudbury, Ontario, Канада, P3C 5K7
- Local Institution
-
Sudbury, Ontario, Канада, P3E 2N8
- Local Institution
-
Sudbury, Ontario, Канада, P3C5K7
- Local Institution
-
Toronto, Ontario, Канада, M9W 4L6
- Local Institution
-
Toronto, Ontario, Канада, M5B 1W8
- Local Institution
-
Weston, Ontario, Канада, M9N 1W4
- Local Institution
-
-
Prince Edward Island
-
Charlottetown, Prince Edward Island, Канада, C1A 5Y9
- Local Institution
-
-
Quebec
-
Drummondville, Quebec, Канада, J2B 7T1
- Local Institution
-
Greenfield Park, Quebec, Канада, J4V 2G8
- Local Institution
-
Lachine, Quebec, Канада, H8S 2E4
- Local Institution
-
Levis, Quebec, Канада, G6V 4Z5
- Local Institution
-
Longueuil, Quebec, Канада, J4K 1C8
- Local Institution
-
Longueuil, Quebec, Канада, J4N 0C9
- Local Institution
-
Longueuil, Quebec, Канада, J4N 1C2
- Local Institution
-
Montreal, Quebec, Канада, H3T 1E2
- Local Institution
-
Montreal, Quebec, Канада, H3A 1A1
- Local Institution
-
Montreal, Quebec, Канада, H1T 1C8
- Local Institution
-
Montreal, Quebec, Канада, H2W 1T8
- Local Institution
-
Montreal, Quebec, Канада, W3R-153
- Local Institution
-
Pointe- Claire, Quebec, Канада, H9R 3J1
- Local Institution
-
St-Lambert, Quebec, Канада, J4P 2H4
- Local Institution
-
Ste-Foy, Quebec, Канада, G1W 4R4
- Local Institution
-
-
Saskatchewan
-
Saskatoon, Saskatchewan, Канада, S7L OY7
- Local Institution
-
-
-
-
Beijing
-
Beijing, Beijing, Китай, 100050
- Local Institution
-
Beijing, Beijing, Китай, 100001
- Local Institution
-
Beijing, Beijing, Китай, 100853
- Local Institution
-
Beijing, Beijing, Китай, 100020
- Local Institution
-
Beijing, Beijing, Китай, 100088
- Local Institution
-
Beijing, Beijing, Китай, 100101
- Local Institution
-
-
Gansu
-
Lanzhou, Gansu, Китай, 730000
- Local Institution
-
Lanzhou, Gansu, Китай, 730030
- Local Institution
-
-
Guangdong
-
Guangzhou, Guangdong, Китай, 510080
- Local Institution
-
Guangzhou, Guangdong, Китай, 510120
- Local Institution
-
-
Hebei
-
Shijiazhuang, Hebei, Китай, 050000
- Local Institution
-
-
Heilongjiang
-
Daqing, Heilongjiang, Китай, 163001
- Local Institution
-
Haerbin, Heilongjiang, Китай, 150086
- Local Institution
-
Haerbin, Heilongjiang, Китай, 150001
- Local Institution
-
-
Hubei
-
Wuhan, Hubei, Китай, 430060
- Local Institution
-
-
Hunan
-
Changsha, Hunan, Китай, 410000
- Local Institution
-
-
Jiangsu
-
Hangzhou, Jiangsu, Китай, 310009
- Local Institution
-
Nanjing, Jiangsu, Китай, 210029
- Local Institution
-
-
Liaoning
-
Dalian, Liaoning, Китай, 116011
- Local Institution
-
Dalian, Liaoning, Китай, 116021
- Local Institution
-
Dalian, Liaoning, Китай, 116027
- Local Institution
-
Shenyang, Liaoning, Китай, 110016
- Local Institution
-
Shenyang, Liaoning, Китай, 110003
- Local Institution
-
-
Shandong
-
Jinan, Shandong, Китай, 250012
- Local Institution
-
Jinan, Shandong, Китай, 250033
- Local Institution
-
Qingdao, Shandong, Китай, 266011
- Local Institution
-
-
Shanghai
-
Shanghai, Shanghai, Китай, 200080
- Local Institution
-
Shanghai, Shanghai, Китай, 200025
- Local Institution
-
Shanghai, Shanghai, Китай, 200433
- Local Institution
-
Shanghai, Shanghai, Китай, 200011
- Local Institution
-
Shanghai, Shanghai, Китай, 200233
- Local Institution
-
Shanghai, Shanghai, Китай, 200003
- Local Institution
-
Shanghai, Shanghai, Китай, 100037
- Local Institution
-
Shanghai, Shanghai, Китай, 200031
- Local Institution
-
-
Sichuan
-
Chengdu, Sichuan, Китай, 610041
- Local Institution
-
Chongqing, Sichuan, Китай, 400010
- Local Institution
-
-
Zhejiang
-
Hangzhou, Zhejiang, Китай, 310009
- Local Institution
-
-
-
-
-
Barranquilla, Колумбия
- Local Institution
-
Barranquilla, Колумбия, XXXXX
- Local Institution
-
Bogota, Колумбия
- Local Institution
-
Bogota, Колумбия, 000
- Local Institution
-
Cali, Колумбия
- Local Institution
-
Medellin, Колумбия
- Local Institution
-
-
Antioquia
-
Medellin, Antioquia, Колумбия
- Local Institution
-
-
-
-
-
Busan, Корея, Республика, 602-702
- Local Institution
-
Daegu, Корея, Республика, 700-712
- Local Institution
-
Daegu, Корея, Республика, 705-717
- Local Institution
-
Daejon, Корея, Республика, 302-718
- Local Institution
-
Goyang, Корея, Республика, 411-706
- Local Institution
-
Gwang Ju, Корея, Республика, 501-757
- Local Institution
-
Gyeonggi, Корея, Республика, 463-707
- Local Institution
-
Pusan, Корея, Республика, 602-739
- Local Institution
-
Scongnam-Si, Корея, Республика, 463-712
- Local Institution
-
Seoul, Корея, Республика, 110-744
- Local Institution
-
Seoul, Корея, Республика, 143-729
- Local Institution
-
Seoul, Корея, Республика, 130-709
- Local Institution
-
Suwon, Корея, Республика, 443-721
- Local Institution
-
-
Gyeonggi-Do
-
Anyang-Si, Gyeonggi-Do, Корея, Республика, 431-070
- Local Institution
-
-
Korea
-
Incheon, Korea, Корея, Республика, 400-711
- Local Institution
-
-
-
-
-
Kuala Lumpur, Малайзия, 56000
- Local Institution
-
Kuala Lumpur, Малайзия, 59100
- Local Institution
-
-
Kelantan
-
Kubang Kerian, Kelantan, Малайзия, 16150
- Local Institution
-
-
Sarawak
-
Kota Samarahan, Sarawak, Малайзия, 94300
- Local Institution
-
-
Selangor
-
Batu Caves, Selangor, Малайзия, 68100
- Local Institution
-
-
-
-
-
Puebla, Мексика, 11490
- Local Institution
-
Queretaro, Мексика, 76000
- Local Institution
-
-
BAJA California
-
Tijuana, BAJA California, Мексика, 22500
- Local Institution
-
-
Distrito Federal
-
Col. Toriello Guerra, Distrito Federal, Мексика, CP 14050
- Local Institution
-
Mexico City, Distrito Federal, Мексика, 06726
- Local Institution
-
Mexico City, Distrito Federal, Мексика, 14080
- Local Institution
-
Mexico City, Distrito Federal, Мексика, 07760
- Local Institution
-
Mexico City, Distrito Federal, Мексика, 06070
- Local Institution
-
Mexico City, Distrito Federal, Мексика, 10700
- Local Institution
-
-
Jalisco
-
Guadalajara, Jalisco, Мексика, 44200
- Local Institution
-
Guadalajara, Jalisco, Мексика, 44600
- Local Institution
-
Guadalajara, Jalisco, Мексика, 44656
- Local Institution
-
-
Michoacan
-
Morelia, Michoacan, Мексика, 58000
- Local Institution
-
-
Nuevo LEON
-
Monterrey, Nuevo LEON, Мексика, 64710
- Local Institution
-
Monterrey, Nuevo LEON, Мексика, 64000
- Local Institution
-
Monterrey, Nuevo LEON, Мексика, 64700
- Local Institution
-
-
Sinaloa
-
Culiacan, Sinaloa, Мексика, 80020
- Local Institution
-
-
Veracruz
-
Jalapa, Veracruz, Мексика, 91020
- Local Institution
-
-
-
-
-
Breda, Нидерланды, 4818 CK
- Local Institution
-
Deventer, Нидерланды, 7416 SE
- Local Institution
-
Eindhoven, Нидерланды, 5623 EJ
- Local Institution
-
Eindhoven, Нидерланды, 5623EJ
- Local Institution
-
Enschede, Нидерланды, 7513 ER
- Local Institution
-
Hardenberg, Нидерланды, 7772 SE
- Local Institution
-
Hilversum, Нидерланды, 1213 XZ
- Local Institution
-
Nijmegen, Нидерланды, 6525 GA
- Local Institution
-
Oss, Нидерланды, 5342 BT
- Local Institution
-
Rotterdam, Нидерланды, 3045 PM
- Local Institution
-
S-Hertogenbosch, Нидерланды, 5211 NL
- Local Institution
-
Tiel, Нидерланды, 4002 WP
- Local Institution
-
Utrecht, Нидерланды, 3582 KE
- Local Institution
-
Velp, Нидерланды, 6883 AZ
- Local Institution
-
-
-
-
-
Alesund, Норвегия, 6003
- Local Institution
-
Bergen, Норвегия, 5021
- Local Institution
-
Bergen, Норвегия, N-5021
- Local Institution
-
Elverum, Норвегия, 2408
- Local Institution
-
Flekkefjord, Норвегия, 4400
- Local Institution
-
Nesttun, Норвегия, 5221
- Local Institution
-
Oslo, Норвегия, 0407
- Local Institution
-
Skien, Норвегия, 3710
- Local Institution
-
Stavanger, Норвегия, 4064
- Local Institution
-
Straume, Норвегия, 5353
- Local Institution
-
Tonsberg, Норвегия, 3116
- Local Institution
-
Tromso, Норвегия, 9038
- Local Institution
-
-
-
-
-
Lima, Перу, LIMA 33
- Local Institution
-
Lima, Перу, LIMA 01
- Local Institution
-
Lima, Перу, LIMA 1
- Local Institution
-
-
Callao
-
Bellavista, Callao, Перу, 2176
- Local Institution
-
Bellavista, Callao, Перу, CALLAO 2
- Local Institution
-
-
Lambayeque
-
Chiclayo, Lambayeque, Перу, CIX
- Local Institution
-
-
Lima
-
Jesus Maria, Lima, Перу, 11
- Local Institution
-
Jesus Maria, Lima, Перу, LIMA 11
- Local Institution
-
Miraflores, Lima, Перу, LIMA 18
- Local Institution
-
San Borja, Lima, Перу, LIMA 41
- Local Institution
-
San Martin De Porres, Lima, Перу, LIMA 31
- Local Institution
-
-
-
-
-
Gdynia, Польша, 81-423
- Local Institution
-
Gdynia, Польша, 81-472
- Local Institution
-
Gdynia, Польша, 81-519
- Local Institution
-
Grodzisk Mazowiecki, Польша, 05-825
- Local Institution
-
Inowroclaw, Польша, 88-100
- Local Institution
-
Kielce, Польша, 25-736
- Local Institution
-
Kielce, Польша, 25-763
- Local Institution
-
Krakow, Польша, 31-202
- Local Institution
-
Krakow, Польша, 30-092
- Local Institution
-
Krakow, Польша, 31-135
- Local Institution
-
Lodz, Польша, 91-347
- Local Institution
-
Lodz, Польша, 91347
- Local Institution
-
Piotrkow Trybunalski, Польша, 97-300
- Local Institution
-
Plock, Польша, 09-402
- Local Institution
-
Plock, Польша, 09-400
- Local Institution
-
Plonsk, Польша, 09-100
- Local Institution
-
Poznan, Польша, 60-531
- Local Institution
-
Poznan, Польша, 60479
- Local Institution
-
Ruda Slaska, Польша, 41-703
- Local Institution
-
Skierniewice, Польша, 96-100
- Local Institution
-
Slupsk, Польша, 76-200
- Local Institution
-
Torun, Польша, 87100
- Local Institution
-
Warszawa, Польша, 01-138
- Local Institution
-
Warszawa, Польша, 04-073
- Local Institution
-
Warszawa, Польша, 04-628
- Local Institution
-
Warszawa, Польша, 04-749
- Local Institution
-
Wegrow, Польша, 07100
- Local Institution
-
-
-
-
-
Cayey, Пуэрто-Рико, 00736
- Local Institution
-
Cidra, Пуэрто-Рико, 00739
- Local Institution
-
Ponce, Пуэрто-Рико, 00717
- Local Institution
-
-
-
-
-
Chelyabinsk, Российская Федерация, 454136
- Local Institution
-
Chita, Российская Федерация, 672090
- Local Institution
-
Dzerzhinskiy, Российская Федерация, 140091
- Local Institution
-
Kazan, Российская Федерация, 420012
- Local Institution
-
Kemerovo, Российская Федерация, 650002
- Local Institution
-
Kirovsk, Российская Федерация, 187342
- Local Institution
-
Krasnodar, Российская Федерация, 350042
- Local Institution
-
Moscow, Российская Федерация, 119992
- Local Institution
-
Moscow, Российская Федерация, 125367
- Local Institution
-
Moscow, Российская Федерация, 109240
- Local Institution
-
Moscow, Российская Федерация, 105229
- Local Institution
-
Moscow, Российская Федерация, 111539
- Local Institution
-
Moscow, Российская Федерация, 115487
- Local Institution
-
Moscow, Российская Федерация, 115093
- Local Institution
-
Moscow, Российская Федерация, 121552
- Local Institution
-
Moscow, Российская Федерация, 117593
- Local Institution
-
Moscow, Российская Федерация, 127018
- Local Institution
-
Moscow, Российская Федерация, 125284
- Local Institution
-
Moscow, Российская Федерация, 111020
- Local Institution
-
Moscow, Российская Федерация, 119121
- Local Institution
-
Moscow, Российская Федерация, 121356
- Local Institution
-
Moscow, Российская Федерация, 117556
- Local Institution
-
Moscow, Российская Федерация, 119048
- Local Institution
-
Moscow, Российская Федерация, 123182
- Local Institution
-
Moscow, Российская Федерация, 125206
- Local Institution
-
Moscow, Российская Федерация, 125424
- Local Institution
-
Moscow, Российская Федерация, 129090
- Local Institution
-
Nizhni Novgorod, Российская Федерация, 603003
- Local Institution
-
Nizhni Novgorod, Российская Федерация, 603005
- Local Institution
-
Novosibirsk, Российская Федерация, 630008
- Local Institution
-
Novosibirsk, Российская Федерация, 630054
- Local Institution
-
Odintsovo, Российская Федерация, 143000
- Local Institution
-
Penza, Российская Федерация, 440026
- Local Institution
-
Perm, Российская Федерация, 614097
- Local Institution
-
Rostov-On-Don, Российская Федерация, 344022
- Local Institution
-
Ryazan, Российская Федерация, 390026
- Local Institution
-
Saint Petersburg, Российская Федерация, 193312
- Local Institution
-
Saint Petersburg, Российская Федерация, 193144
- Local Institution
-
Saint-Petersburg, Российская Федерация, 190103
- Local Institution
-
Saint-Petersburg, Российская Федерация, 191025
- Local Institution
-
Saint-Petersburg, Российская Федерация, 193163
- Local Institution
-
Saint-Petersburg, Российская Федерация, 196601
- Local Institution
-
Saint-Petersburg, Российская Федерация, 198013
- Local Institution
-
Samara, Российская Федерация, 443070
- Local Institution
-
Saratov, Российская Федерация, 410002
- Local Institution
-
St Petersburg, Российская Федерация, 198013
- Local Institution
-
St Petersburg, Российская Федерация, 192288
- Local Institution
-
St-Petersburg, Российская Федерация, 194354
- Local Institution
-
St-Petersburg, Российская Федерация, 195271
- Local Institution
-
St. Petersburg, Российская Федерация, 197341
- Local Institution
-
St. Petersburg, Российская Федерация, 197110
- Local Institution
-
St.-Petersburg, Российская Федерация, 197341
- Local Institution
-
St.Petersburg, Российская Федерация, 199106
- Local Institution
-
Tomsk, Российская Федерация, 634012
- Local Institution
-
Tumen, Российская Федерация, 625023
- Local Institution
-
Tver, Российская Федерация, 170036
- Local Institution
-
Voronezh, Российская Федерация, 394066
- Local Institution
-
Voronezh, Российская Федерация, 394065
- Local Institution
-
Yaroslavl, Российская Федерация, 150030
- Local Institution
-
Yaroslavl, Российская Федерация, 150003
- Local Institution
-
Yaroslavl, Российская Федерация, 150002
- Local Institution
-
Zheleznodorozhniy, Российская Федерация, 143920
- Local Institution
-
Zhukovsky, Российская Федерация, 140160
- Local Institution
-
Zhukovsky, Российская Федерация, 140180
- Local Institution
-
-
-
-
-
Baia Mare, Румыния, 430031
- Local Institution
-
Bucharest, Румыния, 011192
- Local Institution
-
Bucharest, Румыния, 020125
- Local Institution
-
Bucharest, Румыния, 050098
- Local Institution
-
Bucharest, Румыния, 021659
- Local Institution
-
Bucharest, Румыния, 030572
- Local Institution
-
Cluj Napoca, Румыния, 400001
- Local Institution
-
Cluj Napoca, Румыния, 400347
- Local Institution
-
Iasi, Румыния, 700503
- Local Institution
-
Oradea, Румыния, 410169
- Local Institution
-
Sibiu, Румыния, 550245
- Local Institution
-
Targu-Mures, Румыния, 540103
- Local Institution
-
Timisoara, Румыния, 300024
- Local Institution
-
Timisoara, Румыния, 300320
- Local Institution
-
Tirgu Mures, Румыния, 540136
- Local Institution
-
-
-
-
-
Singapore, Сингапур, 168752
- Local Institution
-
-
-
-
-
Antrim, Соединенное Королевство, BT41 2RL
- Local Institution
-
Blackpool, Соединенное Королевство, FY3 8NR
- Local Institution
-
Glasgow, Соединенное Королевство, G21 3UW
- Local Institution
-
-
Aberdeenshire
-
Aberdeen, Aberdeenshire, Соединенное Королевство, AB25 2ZN
- Local Institution
-
Glasgow, Aberdeenshire, Соединенное Королевство, G11 6NT
- Local Institution
-
-
Antrim
-
Belfast, Antrim, Соединенное Королевство, BT14 6AB
- Local Institution
-
-
Armagh
-
Craigavon, Armagh, Соединенное Королевство, BT63 5QQ
- Local Institution
-
-
Cambridgeshire
-
Cambridge, Cambridgeshire, Соединенное Королевство, CB2 2QQ
- Local Institution
-
Peterborough, Cambridgeshire, Соединенное Королевство, PE2 5GP
- Local Institution
-
-
Derbyshire
-
Chesterfield, Derbyshire, Соединенное Королевство, S44 5BL
- Local Institution
-
Chesterfield, Derbyshire, Соединенное Королевство, S40 4TF
- Local Institution
-
-
Dorset
-
Bournemouth, Dorset, Соединенное Королевство, BH7 7DW
- Local Institution
-
-
Dumbartonshire
-
Glasgow, Dumbartonshire, Соединенное Королевство, G11 6NT
- Local Institution
-
-
EAST Sussex
-
Chichester, EAST Sussex, Соединенное Королевство, PO19 6SE
- Local Institution
-
-
Essex
-
Colchester, Essex, Соединенное Королевство, C03 4LN
- Local Institution
-
Romford, Essex, Соединенное Королевство, RH7 0AG
- Local Institution
-
-
Greater London
-
Denmark Hill, Greater London, Соединенное Королевство, SE5 9RS
- Local Institution
-
London, Greater London, Соединенное Королевство, SW17 0RE
- Local Institution
-
-
Gwent
-
Newport, Gwent, Соединенное Королевство, NP20 2UB
- Local Institution
-
-
Hertfordshire
-
Barnet, Hertfordshire, Соединенное Королевство, EN5 3DJ
- Local Institution
-
-
MID Glamorgan
-
Cardiff, MID Glamorgan, Соединенное Королевство, CF14 4XW
- Local Institution
-
Llandough, MID Glamorgan, Соединенное Королевство, CF64 2XX
- Local Institution
-
-
Middlesex
-
Harrow, Middlesex, Соединенное Королевство, HA1 3UJ
- Local Institution
-
-
Nottinghamshire
-
Nottingham, Nottinghamshire, Соединенное Королевство, NG5 1PB
- Local Institution
-
Worksop, Nottinghamshire, Соединенное Королевство, S81 OBD
- Local Institution
-
-
Renfrewshire
-
Paisley, Renfrewshire, Соединенное Королевство, PA2 9PN
- Local Institution
-
-
South Yorkshire
-
Barnsley, South Yorkshire, Соединенное Королевство, S75 2EP
- Local Institution
-
Doncaster, South Yorkshire, Соединенное Королевство, DN2 5LT
- Local Institution
-
-
Stirlingshire
-
Stirling, Stirlingshire, Соединенное Королевство, FK8 2AU
- Local Institution
-
-
Strathclyde
-
Glasgow, Strathclyde, Соединенное Королевство, G51 4TF
- Local Institution
-
-
Suffolk
-
Bury St Edmunds, Suffolk, Соединенное Королевство, IP31 2HD
- Local Institution
-
Bury St Edmunds, Suffolk, Соединенное Королевство, IP33 2QZ
- Local Institution
-
Bury St. Edmunds, Suffolk, Соединенное Королевство, IP30 9QU
- Local Institution
-
Ipswich, Suffolk, Соединенное Королевство, IP14 2PU
- Local Institution
-
Ipswich, Suffolk, Соединенное Королевство, IP7 5DN
- Local Institution
-
-
Tyne and Wear
-
Newcastle Upon Tyne, Tyne and Wear, Соединенное Королевство, NE1 4LP
- Local Institution
-
-
WEST Glamorgan
-
Swansea, WEST Glamorgan, Соединенное Королевство, SA6 6NL
- Local Institution
-
-
WEST Lothian
-
Livingston, WEST Lothian, Соединенное Королевство, EH54 6PP
- Local Institution
-
-
WEST Midlands
-
Birmingham, WEST Midlands, Соединенное Королевство, B18 7QH
- Local Institution
-
-
Wiltshire
-
Westbury, Wiltshire, Соединенное Королевство, BA 13 3JD
- Local Institution
-
Westbury, Wiltshire, Соединенное Королевство, BA13 3JD
- Local Institution
-
-
Yorkshire
-
York, Yorkshire, Соединенное Королевство, YO31 8HE
- Local Institution
-
York, Yorkshire, Соединенное Королевство, YO31 HE
- Local Institution
-
-
-
-
Alabama
-
Birmingham, Alabama, Соединенные Штаты, 35209
- Cardiovascular Associates, Pc
-
Birmingham, Alabama, Соединенные Штаты, 35235
- Alabama Internal Medicine Pc
-
Birmingham, Alabama, Соединенные Штаты, 35235
- Birmingham Heart Clinic P.C.
-
Huntsville, Alabama, Соединенные Штаты, 35801
- Heart Center, Inc.
-
Mobile, Alabama, Соединенные Штаты, 36608
- Mobile Heart Specialists, PC
-
Mobile, Alabama, Соединенные Штаты, 36617
- Clara V. Massey, Md
-
-
Alaska
-
Anchorage, Alaska, Соединенные Штаты, 99508
- Alaska Heart Institute
-
-
Arizona
-
Phoenix, Arizona, Соединенные Штаты, 85006
- Internal Medicine Physicians Associates, P.C.
-
Tucson, Arizona, Соединенные Штаты, 85723
- Southern Arizona VA Health Care System
-
Tucson, Arizona, Соединенные Штаты, 85710
- Southwest Heart
-
Tucson, Arizona, Соединенные Штаты, 85745
- Pima Research Foundation
-
-
Arkansas
-
Hot Springs, Arkansas, Соединенные Штаты, 71913
- Dr. Rajesh Shroff
-
Little Rock, Arkansas, Соединенные Штаты, 72204
- Mary K. Richards, Md Pa
-
-
California
-
Anaheim, California, Соединенные Штаты, 92801
- Advanced Clinical Reserach Institute
-
Beverly Hills, California, Соединенные Штаты, 90210
- Act/Cardiovascular Research Institute
-
Carmichael, California, Соединенные Штаты, 95608
- Capitol Interventional Cardiology
-
Escondido, California, Соединенные Штаты, 92025
- Escondido Cardiology Associates, Inc.
-
Healdsburg, California, Соединенные Штаты, 95448
- William D. Bowden, D.O.
-
La Mesa, California, Соединенные Штаты, 91942
- La Mesa Cardiac Center, A Medical Group
-
Los Angeles, California, Соединенные Штаты, 90073
- VA Greater Los Angeles Healthcare System
-
Mission Viejo, California, Соединенные Штаты, 92691
- Coastal Cardiology
-
Oceanside, California, Соединенные Штаты, 92056
- Kenneth W. Carr Md
-
Palm Springs, California, Соединенные Штаты, 92262
- Desert Med Grp Inc, Dba Desert Oasis Healthcare Med Group
-
Rancho Mirage, California, Соединенные Штаты, 92270
- Desert Cardiology Consultants Medical Group, Inc
-
Sacramento, California, Соединенные Штаты, 95821
- Northern California Research
-
Sacramento, California, Соединенные Штаты, 95825
- Sacramento Heart And Vascular Medical Associates
-
Sacramento, California, Соединенные Штаты, 95819
- Regional Cardiolody Associates
-
Santa Barbara, California, Соединенные Штаты, 93105
- Arrhythmia Consultants Of The Central Coast Medical Group
-
Santa Rosa, California, Соединенные Штаты, 95403
- Northern California Medical Associates
-
Vista, California, Соединенные Штаты, 92083
- Progressive Clinical Research
-
Walnut Creek, California, Соединенные Штаты, 94598
- Cardivasclular Consultants Medical Group
-
Wildomar, California, Соединенные Штаты, 92595
- Shiva Heart Center Medical Group
-
-
Colorado
-
Colorado Springs, Colorado, Соединенные Штаты, 80910
- Electrophysiology Associates, Pc
-
Denver, Colorado, Соединенные Штаты, 80220
- Denver VA Medical Center
-
Denver, Colorado, Соединенные Штаты, 80218
- Aurora Denver Cardiology Associates, P.C.
-
Golden, Colorado, Соединенные Штаты, 80401
- New West Physicians Clinical Research
-
Littleton, Colorado, Соединенные Штаты, 80120
- South Denver Cardiology Associates PC
-
-
Connecticut
-
Bridgeport, Connecticut, Соединенные Штаты, 06610
- Bridgeport Hospital
-
Bridgeport, Connecticut, Соединенные Штаты, 06606
- Connecticut Clinical Research, Llc
-
Guilford, Connecticut, Соединенные Штаты, 06437
- Cardiology Associates Of New Haven,Pc
-
Norwich, Connecticut, Соединенные Штаты, 06360
- William W Backus Hospital
-
Norwich, Connecticut, Соединенные Штаты, 06360
- The William W. Backus Hospital
-
Stamford, Connecticut, Соединенные Штаты, 06905
- Stamford Therapeutics Consortium
-
Waterbury, Connecticut, Соединенные Штаты, 06708
- Chase Medical Research, LLC
-
-
Delaware
-
Newark, Delaware, Соединенные Штаты, 19713
- Alfieri Cardiology
-
-
District of Columbia
-
Washington, District of Columbia, Соединенные Штаты, 20422
- Washington VA Medical Center
-
Washington, District of Columbia, Соединенные Штаты, 20037
- George Washington University Medical Faculty Associates
-
-
Florida
-
Atlantis, Florida, Соединенные Штаты, 33462
- Medical Specialist Of The Palm Beach
-
Aventura, Florida, Соединенные Штаты, 33180
- Miami International Cardiology Consultants
-
Boca Raton, Florida, Соединенные Штаты, 33431
- David Charles Mishkel, Md, Pa
-
Clearwater, Florida, Соединенные Штаты, 33756
- The Heart & Vascular Institute Of Florida
-
Clearwater, Florida, Соединенные Штаты, 33756
- The Heart And Vascular Institute Of Florida
-
Davie, Florida, Соединенные Штаты, 33324
- Cardiovascular Specialist Of South Florida
-
Daytona Beach, Florida, Соединенные Штаты, 32114
- Daytona Heart Group
-
Fort Lauderdale, Florida, Соединенные Штаты, 33316
- Broward General Medical Center
-
Fort Lauderdale, Florida, Соединенные Штаты, 33308
- Cardiology Associates Of Fort Lauderdale, P.A.
-
Fort Myers, Florida, Соединенные Штаты, 33907
- Florida Heart Associates
-
Gainesville, Florida, Соединенные Штаты, 32605
- Florida Research Network, LLC
-
Hollywood, Florida, Соединенные Штаты, 33021
- Healthworx
-
Hollywood, Florida, Соединенные Штаты, 33021
- Luis Tami, Md
-
Inverness, Florida, Соединенные Штаты, 34452
- Nature Coast Clinical Research
-
Jacksonville, Florida, Соединенные Штаты, 32216
- Jacksonville Center for Clinical Research
-
Jacksonville, Florida, Соединенные Штаты, 32216
- Jacksonville Cardiovascular Center
-
Jacksonville, Florida, Соединенные Штаты, 32258
- Jacksonville Heart Center, Pa
-
Jacksonville, Florida, Соединенные Штаты, 32204
- St. Vincent'S Ambulatory Care, Inc
-
Jacksonville, Florida, Соединенные Штаты, 32207
- Jacksonville Heart Center, Pa
-
Jacksonville, Florida, Соединенные Штаты, 32216
- St. Luke'S Cardiology
-
Jacksonville Beach, Florida, Соединенные Штаты, 32250
- Jacksonville Heart Center, P.A.
-
Jupiter, Florida, Соединенные Штаты, 33458
- Cvms Research Institute, Llc
-
Jupiter, Florida, Соединенные Штаты, 33458
- Ricardo Bedoya, M.D.
-
Melbourne, Florida, Соединенные Штаты, 32901
- Melbourne Internal Medicine Associates
-
Miami, Florida, Соединенные Штаты, 33137
- Miami International Cardiology Consultants
-
Miami, Florida, Соединенные Штаты, 33137-3732
- Miami International Cardiology Consultants
-
Naples, Florida, Соединенные Штаты, 34119
- Physicians Regional Medical Group
-
Orlando, Florida, Соединенные Штаты, 32803
- Florida Heart Group
-
Oviedo, Florida, Соединенные Штаты, 32765
- Alpha Medical Research
-
Pensacola, Florida, Соединенные Штаты, 32501
- Cardiology Consultants
-
Saint Petersburg, Florida, Соединенные Штаты, 33709
- The Heart And Vascular Institute Of Florida
-
Sarasota, Florida, Соединенные Штаты, 34239
- Heart & Vascular Center Research, Inc.
-
Sarasota, Florida, Соединенные Штаты, 34232
- Niranjan Seshadri, Md
-
Vero Beach, Florida, Соединенные Штаты, 32960
- Research, Inc.
-
-
Georgia
-
Atlanta, Georgia, Соединенные Штаты, 30342
- Cardiovascular Specialits, Pc
-
Augusta, Georgia, Соединенные Штаты, 30901
- Augusta Cardiology Clinic, P.C.
-
Columbus, Georgia, Соединенные Штаты, 31909
- Columbus Cardiology Associates Pc
-
Columbus, Georgia, Соединенные Штаты, 31909
- Columbus Cardiology Associates,Pc
-
Covington, Georgia, Соединенные Штаты, 30014
- Georgia Heart Specialists, L.L.C.
-
Decatur, Georgia, Соединенные Штаты, 30030
- Atlanta Institute For Medical Research, Inc
-
Gainesville, Georgia, Соединенные Штаты, 30501
- Northeast Georgia Heart Center, PC
-
Marietta, Georgia, Соединенные Штаты, 30060
- Wellstar Cardiovascular Medicine, Pc
-
-
Illinois
-
Aurora, Illinois, Соединенные Штаты, 60504
- Fox Valley Clinical Research Center, LLC
-
Chicago, Illinois, Соединенные Штаты, 60611
- Nmff
-
Gurnee, Illinois, Соединенные Штаты, 60031
- Clinical Investigation Specialists, Inc
-
Maywood, Illinois, Соединенные Штаты, 60153
- Loyola University Medical Center
-
Normal, Illinois, Соединенные Штаты, 61761
- Illinois Heart & Lung Research Center, Sc
-
North Chicago, Illinois, Соединенные Штаты, 60064
- Cpt. James A Lovell Federal Health Care Center
-
-
Indiana
-
Anderson, Indiana, Соединенные Штаты, 46011
- Community Clinical Research Center
-
Bloomington, Indiana, Соединенные Штаты, 47403
- Premier Healthcare, Llc
-
Elkhart, Indiana, Соединенные Штаты, 46514
- Elkhart Clinic, LLC
-
Fort Wayne, Indiana, Соединенные Штаты, 46804
- Lutheran Medical Group, Llc
-
Fort Wayne, Indiana, Соединенные Штаты, 46805
- Fort Wayne Cardiology
-
Indianapolis, Indiana, Соединенные Штаты, 46290
- The Care Group, Llc
-
Indianapolis, Indiana, Соединенные Штаты, 46290
- The Care Group, Llc.
-
Indianapolis, Indiana, Соединенные Штаты, 46237
- St Francis Medical Group - Indiana Heart Physicians
-
Michigan City, Indiana, Соединенные Штаты, 46360
- Dali, Sammi
-
South Bend, Indiana, Соединенные Штаты, 46601
- Cardiology Associates, Inc.
-
-
Iowa
-
Ames, Iowa, Соединенные Штаты, 50010
- McFarland Clinic PC
-
-
Kansas
-
Overland Park, Kansas, Соединенные Штаты, 66209
- Midwest Cardiology Associates , P.C.
-
-
Kentucky
-
Elizabethtown, Kentucky, Соединенные Штаты, 42701
- Central Cardiology Assoc.
-
Lexington, Kentucky, Соединенные Штаты, 40504
- New Lexington Clinic, P.S.C.
-
Louisville, Kentucky, Соединенные Штаты, 40205
- Norton Cardiovascular Associates
-
Louisville, Kentucky, Соединенные Штаты, 40202
- VA Medical Center
-
Owensboro, Kentucky, Соединенные Штаты, 42303
- Owensboro Heart & Vascular
-
-
Louisiana
-
Alexandria, Louisiana, Соединенные Штаты, 71301
- Alexandria Cardiology Clinic
-
Houma, Louisiana, Соединенные Штаты, 70360
- Cardiovascular Institute of the South
-
Lacombe, Louisiana, Соединенные Штаты, 70445
- Smith, Patel & Amkieh, Llc
-
Lake Charles, Louisiana, Соединенные Штаты, 70601
- Imperial Calcasieu Medical Group, Llp
-
Marrero, Louisiana, Соединенные Штаты, 70072
- Cardiology Center, Llc
-
Shreveport, Louisiana, Соединенные Штаты, 71105
- Cardiology Associates
-
Slidell, Louisiana, Соединенные Штаты, 70458
- Louisiana Heart Center
-
Slidell, Louisiana, Соединенные Штаты, 70458
- Medical Research Inst, Inc
-
Slidell, Louisiana, Соединенные Штаты, 70458
- Medical Research Institute, Inc
-
Ventura, Louisiana, Соединенные Штаты, 93003
- Ventura Cardio. Cond. Med. Group, Inc.
-
-
Maine
-
Lewiston, Maine, Соединенные Штаты, 04240
- Central Maine Heart & Vascular Institute
-
-
Maryland
-
Baltimore, Maryland, Соединенные Штаты, 21224
- Johns Hopkins Bayview Medical Center
-
Baltimore, Maryland, Соединенные Штаты, 21237
- Franklin Square Hospital
-
Baltimore, Maryland, Соединенные Штаты, 21208
- Midatlantic Cardiovascular Associates, Pa
-
Baltimore, Maryland, Соединенные Штаты, 21237
- Midatlantic Cardiovascular Associates, Pa
-
Baltimore, Maryland, Соединенные Штаты, 21204
- Midatlantic Cardiovascular Associates, P.A.
-
Baltimore, Maryland, Соединенные Штаты, 21218
- Midatlantic Cardiovascular Associates, P.A.
-
Baltimore, Maryland, Соединенные Штаты, 21224-2735
- Johns Hopkins Bayview Medical Center
-
Baltimore, Maryland, Соединенные Штаты, 21237
- Midatlantic Cardiovascular Associates, P.A.
-
Bel Air, Maryland, Соединенные Штаты, 21014
- Midatlantic Cardiovascular Associates, Pa
-
Columbia, Maryland, Соединенные Штаты, 21044
- Cardiovascular Specialists Of Central Maryland, P.A.
-
Reisterstown, Maryland, Соединенные Штаты, 21136
- Clinical Associates Research
-
Westminster, Maryland, Соединенные Штаты, 21157
- Midatlantic Cardiovascular Associates, Pa
-
-
Massachusetts
-
Billerica, Massachusetts, Соединенные Штаты, 01821
- Burlington Medical Associates
-
Boston, Massachusetts, Соединенные Штаты, 02135
- Caritas St. Elizabeth's Medical Center
-
Burlington, Massachusetts, Соединенные Штаты, 01805
- Lahey Clinic Medical Center
-
Fall River, Massachusetts, Соединенные Штаты, 02720
- Neccr Internal Medicine & Cardiology Associates,Llc
-
Haverhill, Massachusetts, Соединенные Штаты, 01830
- Pentucket Medical Associates
-
Haverhill, Massachusetts, Соединенные Штаты, 01830-6278
- Pentucket Medical Associates
-
Natick, Massachusetts, Соединенные Штаты, 01760
- Charles River Medical Associates
-
-
Michigan
-
Alpena, Michigan, Соединенные Штаты, 49707
- Great Lakes Heart Center Of Alpena
-
Detroit, Michigan, Соединенные Штаты, 48202
- Henry Ford Hospital
-
Lansing, Michigan, Соединенные Штаты, 48910
- Thoracic And Cardiovascular Healthcare Foundation
-
Livonia, Michigan, Соединенные Штаты, 48154
- Advanced Cardiovascular Health Specialists, Pc
-
Petoskey, Michigan, Соединенные Штаты, 49770
- Michigan Heart And Vascular Specialists
-
Royal Oak, Michigan, Соединенные Штаты, 48073
- William Beaumont Hospital
-
Ypsilanti, Michigan, Соединенные Штаты, 48197
- Michigan Heart, P.C.
-
-
Minnesota
-
Minneapolis, Minnesota, Соединенные Штаты, 55455
- University of Minnesota
-
Minneapolis, Minnesota, Соединенные Штаты, 55417
- Minneapolis VA Medical Center
-
Robbinsdale, Minnesota, Соединенные Штаты, 55422
- North Memorial Health Care
-
-
Mississippi
-
Olive Branch, Mississippi, Соединенные Штаты, 38654
- Olive Branch Family Medical Center
-
Tupelo, Mississippi, Соединенные Штаты, 38801
- Tupelo Neurology Clinic, Pa
-
-
Missouri
-
Columbia, Missouri, Соединенные Штаты, 65212
- University of Missouri
-
Kansas City, Missouri, Соединенные Штаты, 64108
- Truman Medical Center
-
Kansas City, Missouri, Соединенные Штаты, 64111
- Saint Luke's Lipid and Diabetes Research Center
-
-
Nebraska
-
Grand Island, Nebraska, Соединенные Штаты, 68803
- Internal Medical Associates Of Grand Island, P.C
-
Grand Island, Nebraska, Соединенные Штаты, 68803-4311
- Internal Medical Associates Of Grand Island, P.C
-
Hastings, Nebraska, Соединенные Штаты, 68901
- Nebraska Heart Institute
-
-
Nevada
-
Las Vegas, Nevada, Соединенные Штаты, 89106
- VA Southern Nevada Healthcare System
-
-
New Jersey
-
Berlin, New Jersey, Соединенные Штаты, 08009
- Comprehensive Clinical Research
-
Elmer, New Jersey, Соединенные Штаты, 08318
- Cardiovascular Associates Of The Delware Valley, P.A.
-
Haddon Heights, New Jersey, Соединенные Штаты, 08035
- Cardiovascular Associates Of The Delaware Valley, P.A.
-
Princeton, New Jersey, Соединенные Штаты, 08540
- Princeton Medical Institute
-
Sewell, New Jersey, Соединенные Штаты, 08080
- Cardio Assoc Of Del Val, P.A.
-
South Plainfield, New Jersey, Соединенные Штаты, 07080
- Central New Jersey Cardiology
-
-
New Mexico
-
Albuquerque, New Mexico, Соединенные Штаты, 87012
- Abq Health Partners, Llc
-
Albuquerque, New Mexico, Соединенные Штаты, 87131-0001
- University Of New Mexico/University Hospital
-
Albuquerque, New Mexico, Соединенные Штаты, 87131
- University Of New Mexico/University Hospital
-
-
New York
-
Albany, New York, Соединенные Штаты, 12205
- Albany Associates In Cardiology
-
Albany, New York, Соединенные Штаты, 12205
- Albany Assoc. In Cardiology
-
Binghamton, New York, Соединенные Штаты, 13905
- Cardiology Associates, Pc
-
Buffalo, New York, Соединенные Штаты, 14215
- Buffalo Heart Group, LLP
-
Buffalo, New York, Соединенные Штаты, 14215-1145
- Buffalo Heart Group, LLP
-
Buffalo, New York, Соединенные Штаты, 14215
- Bruce L. Platt Md, Pc
-
Buffalo, New York, Соединенные Штаты, 14215
- Bruce L. Platt, Md
-
East Syracuse, New York, Соединенные Штаты, 13057
- Heart Care Center, P.C.
-
Huntington, New York, Соединенные Штаты, 11743
- Huntington Hospital
-
Liverpool, New York, Соединенные Штаты, 13088
- SJH Cardiology Associates
-
Mineola, New York, Соединенные Штаты, 11501
- Long Island Heart Associates
-
Saratoga Springs, New York, Соединенные Штаты, 12866
- Saratoga Cardiology Associates, Pc
-
Williamsville, New York, Соединенные Штаты, 14221
- Office Of Dr. Kozinn
-
Williamsville, New York, Соединенные Штаты, 14221
- Suburban Cardiology
-
-
North Carolina
-
Asheville, North Carolina, Соединенные Штаты, 28803
- Asheville Cardiology Associates
-
Burlington, North Carolina, Соединенные Штаты, 27215
- Kernodle Clinic, Inc.
-
High Point, North Carolina, Соединенные Штаты, 27262
- Carolina Cardiology Associates, Pa
-
Pinehurst, North Carolina, Соединенные Штаты, 28374
- Pinehurst Medical Center, Inc
-
-
North Dakota
-
Fargo, North Dakota, Соединенные Штаты, 58103
- Lillestol Research LLC
-
-
Ohio
-
Akron, Ohio, Соединенные Штаты, 44304
- Akron Cardiology Consultants
-
Bucyrus, Ohio, Соединенные Штаты, 44820
- Christopher M. Johnson, D.O.
-
Bucyrus, Ohio, Соединенные Штаты, OHIO
- Christopher M. Johnson, D.O.
-
Canal Fulton, Ohio, Соединенные Штаты, 44614
- Community Health Care, Inc.
-
Canton, Ohio, Соединенные Штаты, 44710
- Cardiology Associates
-
Cincinnati, Ohio, Соединенные Штаты, 45219
- The Carl & Edyth Lindner Center For R&E At The Christ Hosp
-
Toledo, Ohio, Соединенные Штаты, 43608
- Toledo Cardiology Consultants
-
Wadsworth, Ohio, Соединенные Штаты, 44281
- Family Practice Center of Wadsworth, Inc.
-
-
Oklahoma
-
Muskogee, Oklahoma, Соединенные Штаты, 74401
- Jack C. Va Medical Center
-
Oklahoma City, Oklahoma, Соединенные Штаты, 73104
- University of Oklahoma Health Sciences Center
-
Oklahoma City, Oklahoma, Соединенные Штаты, 73112
- Plaza Medical Group, Pc
-
Oklahoma City, Oklahoma, Соединенные Штаты, 73103
- COR Clinical Research, LLC
-
Oklahoma City, Oklahoma, Соединенные Штаты, 73135
- South Oklahoma Heart Research
-
Oklahoma City, Oklahoma, Соединенные Штаты, 73120
- Oklahoma Heart Hospital Physicians
-
Oklahoma City, Oklahoma, Соединенные Штаты, 73139
- Eminence Research, LLC
-
Tulsa, Oklahoma, Соединенные Штаты, 74136
- Castlerock Clinical Research Consultants, Llc
-
-
Oregon
-
Bend, Oregon, Соединенные Штаты, 97701
- St. Charles Health System, Inc.
-
Bend, Oregon, Соединенные Штаты, 97701
- St. Charles Health System, Inc
-
Eugene, Oregon, Соединенные Штаты, 97401
- Oregon Medical Group - Clinical Research
-
Hillsboro, Oregon, Соединенные Штаты, 97123
- Hillsboro Cardiology Pc
-
Medford, Oregon, Соединенные Штаты, 97504
- Rogue Valley Physicians - Clinical Research Group
-
-
Pennsylvania
-
Abington, Pennsylvania, Соединенные Штаты, 19001
- Abington Medical Specialists
-
Altoona, Pennsylvania, Соединенные Штаты, 16602
- Blair Medical Associates, Inc.
-
Camp Hill, Pennsylvania, Соединенные Штаты, 17011
- Heritage Cardiology Assoc.
-
Doylestown, Pennsylvania, Соединенные Штаты, 18901
- Central Bucks Cardiology
-
Erie, Pennsylvania, Соединенные Штаты, 16509
- Internal Medicine And Lipid Mgmt.
-
Harrisburg, Pennsylvania, Соединенные Штаты, 17112
- Kandra, Fierer, Kuskin Associates
-
Hatfield, Pennsylvania, Соединенные Штаты, 19440
- Pivotal Clinical Research, Llc
-
Jersey Shore, Pennsylvania, Соединенные Штаты, 17740
- Lycoming Internal Medicine Inc.
-
Sayre, Pennsylvania, Соединенные Штаты, 18840
- Guthrie Medical Group, P.C.
-
Sayre, Pennsylvania, Соединенные Штаты, 18840
- Guthrie Clinic Ltd.
-
Uniontown, Pennsylvania, Соединенные Штаты, 15401
- Preferred Primary Care Physicians
-
West Chester, Pennsylvania, Соединенные Штаты, 19380
- West Chester Cardiology, Pc
-
Yardley, Pennsylvania, Соединенные Штаты, 19067
- Cardiology Consultants of Philadelphia
-
-
Rhode Island
-
Providence, Rhode Island, Соединенные Штаты, 02903
- Rhode Island Hospital
-
-
South Carolina
-
Anderson, South Carolina, Соединенные Штаты, 29621
- Southeastern Research Associates, Inc
-
Beaufort, South Carolina, Соединенные Штаты, 29906
- Lowcountry Medical Group, Llc
-
Beaufort, South Carolina, Соединенные Штаты, 29906
- Lowcountry Medical Group
-
Charleston, South Carolina, Соединенные Штаты, 29425
- Medical University of South Carolina
-
Columbia, South Carolina, Соединенные Штаты, 29203
- Columbia Heart Clinic
-
Greenville, South Carolina, Соединенные Штаты, 29607
- Upstate Cardiology
-
Greer, South Carolina, Соединенные Штаты, 29650
- Internal Medicine Of Greer
-
Orangeburg, South Carolina, Соединенные Штаты, 29118
- Palmetto Nephrology Pa
-
Spartanburg, South Carolina, Соединенные Штаты, 29303
- S. Carolina Pharmaceutical Research
-
-
South Dakota
-
Pierre, South Dakota, Соединенные Штаты, 57501
- Avera Medical Associates Clinic
-
-
Tennessee
-
Bristol, Tennessee, Соединенные Штаты, 37620
- Holston Medical Group
-
Kingsport, Tennessee, Соединенные Штаты, 37660
- Holston Medical Group
-
Knoxville, Tennessee, Соединенные Штаты, 37920
- Volunteer Research Group
-
Knoxville, Tennessee, Соединенные Штаты, 37916
- Knoxville Heart Group
-
Knoxville, Tennessee, Соединенные Штаты, 37920-1502
- Volunteer Research Group
-
Tullahoma, Tennessee, Соединенные Штаты, 37388
- Tennessee Center for Clinical Trials
-
-
Texas
-
Amarillo, Texas, Соединенные Штаты, 79106
- Amarillo Heart Clinical Research Institute Inc.
-
Corsicana, Texas, Соединенные Штаты, 75110
- Corsicana Medical Research, PLLC
-
Dallas, Texas, Соединенные Штаты, 75226
- Soltero Cardiovascular Research Center
-
Dallas, Texas, Соединенные Штаты, 75230
- HeartPlace
-
Fort Worth, Texas, Соединенные Штаты, 76104
- Heart Center of North Texas
-
Houston, Texas, Соединенные Штаты, 77030
- The Methodist Hospital
-
Houston, Texas, Соединенные Штаты, 77030
- The University of Texas MD Anderson Cancer Center
-
Houston, Texas, Соединенные Штаты, 77030
- Center For Atrial Fibrillation
-
Houston, Texas, Соединенные Штаты, 77030
- The Methodist Hospital Neurology Institute
-
Houston, Texas, Соединенные Штаты, 77065
- Northwest Houston Cardiology, Pa
-
Houston, Texas, Соединенные Штаты, 77070
- Northwest Houston Cardiology, Pa
-
Houston, Texas, Соединенные Штаты, 77074
- Francisco R. Maislos
-
Houston, Texas, Соединенные Штаты, 77090
- Woodlands North Houston Heart Center
-
Humble, Texas, Соединенные Штаты, 77338
- Regional Medical Center And Diagnostic Clinics
-
Lackland Air Force Base, Texas, Соединенные Штаты, 78236
- Wilford Hall Medical Center
-
Lackland Air Force Base, Texas, Соединенные Штаты, 78236-9908
- Wilford Hall Medical Center
-
Longview, Texas, Соединенные Штаты, 75605
- DCOL Center for Clinical Research
-
McKinney, Texas, Соединенные Штаты, 75069
- North Dallas Research Associates
-
Plano, Texas, Соединенные Штаты, 75093
- North Texas Medical Research
-
Plano, Texas, Соединенные Штаты, 75024
- Legacy Heart Center
-
San Antonio, Texas, Соединенные Штаты, 78229
- Covenant Clinical Research, Pa
-
San Antonio, Texas, Соединенные Штаты, 78217
- Bhs Specialty Network, Inc
-
San Antonio, Texas, Соединенные Штаты, 78229
- Star Clinical Trails
-
Seguin, Texas, Соединенные Штаты, 78155
- Edward Balli, Md, Pa
-
Tomball, Texas, Соединенные Штаты, 77375
- Northwest Heart Center
-
Tyler, Texas, Соединенные Штаты, 75701
- Tyler Cardiovascular Consultants
-
Tyler, Texas, Соединенные Штаты, 75708
- University of Texas Health Science Center at Tyler
-
Tyler, Texas, Соединенные Штаты, 75708
- The Univ. Of Texas Health Science Ctr. At Tyler
-
-
Utah
-
Layton, Utah, Соединенные Штаты, 84041
- Utah Cardiology P.C
-
-
Virginia
-
Norfolk, Virginia, Соединенные Штаты, 23510
- Sentara York Clinical Research
-
Richmond, Virginia, Соединенные Штаты, 23220
- Medical Research Initiatives
-
Roanoke, Virginia, Соединенные Штаты, 24014
- Roanoke Heart Institute, Plc
-
Virginia Beach, Virginia, Соединенные Штаты, 23454
- Cardiovascular Associates
-
-
Washington
-
Burien, Washington, Соединенные Штаты, 98166
- Daniel W. Gottlieb, Md, Ps
-
Burien, Washington, Соединенные Штаты, 98166
- Daniel William Gottlieb, Md
-
Spokane, Washington, Соединенные Штаты, 99202
- Rockwood Clinic Research Cent.
-
Walla Walla, Washington, Соединенные Штаты, 99362
- Walla Walla Clinic
-
-
West Virginia
-
Lewisburg, West Virginia, Соединенные Штаты, 24901
- Lynn N. Smith, Md
-
-
Wisconsin
-
Green Bay, Wisconsin, Соединенные Штаты, 54301
- Cardiology Associates Of Green Bay Ltd-Bellin Hospital
-
Madison, Wisconsin, Соединенные Штаты, 53715
- St. Mary's Hospital
-
Madison, Wisconsin, Соединенные Штаты, 53715
- St.Mary's Hospital
-
Milwaukee, Wisconsin, Соединенные Штаты, 53226
- Medical College of Wisconsin
-
Milwaukee, Wisconsin, Соединенные Штаты, 53215
- Aurora Health Care
-
Waukesha, Wisconsin, Соединенные Штаты, 53188
- Cardiology Assc. Of Waukesha
-
-
-
-
-
Taipei, Тайвань, 100
- Local Institution
-
Taipei, Тайвань, 112
- Local Institution
-
Taipei, Тайвань, 111
- Local Institution
-
Taipei, Тайвань, 220
- Local Institution
-
Taipei, Тайвань, 10449
- Local Institution
-
Taipei, Тайвань, 104
- Local Institution
-
-
-
-
-
Ankara, Турция, 06100
- Local Institution
-
Eskisehir, Турция, 26480
- Local Institution
-
Izmir, Турция, 35100
- Local Institution
-
-
-
-
-
Chernivtsy, Украина, 58013
- Local Institution
-
Dnipropetrovsk, Украина, 49006
- Local Institution
-
Dnipropetrovsk, Украина, 49060
- Local Institution
-
Donetsk, Украина, 83045
- Local Institution
-
Donetsk, Украина, 83003
- Local Institution
-
Donetsk, Украина, 83114
- Local Institution
-
Ivano-Frankivsk, Украина, 76025
- Local Institution
-
Kharkiv, Украина, 61018
- Local Institution
-
Kharkiv, Украина, 61115
- Local Institution
-
Kharkov, Украина, 61039
- Local Institution
-
Kharkov, Украина, 61002
- Local Institution
-
Kharkov, Украина, 61178
- Local Institution
-
Kiev, Украина, 01032
- Local Institution
-
Kyiv, Украина, 03680
- Local Institution
-
Kyiv, Украина, 02091
- Local Institution
-
Kyiv, Украина, 03049
- Local Institution
-
Kyiv, Украина, 03115
- Local Institution
-
Kyiv, Украина, 04050
- Local Institution
-
Kyiv, Украина, 04107
- Local Institution
-
Kyiv, Украина, 01023
- Local Institution
-
Kyiv, Украина, 02660
- Local Institution
-
Kyiv, Украина, 01103
- Local Institution
-
Lugansk, Украина, 91011
- Local Institution
-
Lugansk, Украина, 91016
- Local Institution
-
Lutsk, Украина, 43024
- Local Institution
-
Lviv, Украина, 79013
- Local Institution
-
Lviv, Украина, 79015
- Local Institution
-
Mykolayiv, Украина, 54003
- Local Institution
-
Odessa, Украина, 65009
- Local Institution
-
Odessa, Украина, 65039
- Local Institution
-
Odessa, Украина, 65114
- Local Institution
-
Odessa, Украина, 65025
- Local Institution
-
Uzhgorod, Украина, 88000
- Local Institution
-
Vinnitsa, Украина, 21029
- Local Institution
-
Zaporozhye, Украина, 69035
- Local Institution
-
Zhytomyr, Украина, 10002
- Local Institution
-
-
-
-
-
Manila, Филиппины, 1000
- Local Institution
-
Manila, Филиппины, 1008
- Local Institution
-
Naga City, Филиппины, 4400
- Local Institution
-
Pasig City, Филиппины, 1600
- Local Institution
-
Quezon, Филиппины, 1100
- Local Institution
-
Quezon City, Филиппины, 1102
- Local Institution
-
San Juan, Филиппины, 1100
- Local Institution
-
-
Ilocos Norte
-
Laoag City, Ilocos Norte, Филиппины, 2900
- Local Institution
-
-
-
-
-
Helsinki, Финляндия, 00280
- Local Institution
-
Helsinki, Финляндия, FI-00280
- Local Institution
-
Hus, Финляндия, 00029
- Local Institution
-
Jyvaskyla, Финляндия, 40100
- Local Institution
-
Kemi, Финляндия, 94100
- Local Institution
-
Oulu, Финляндия, 90100
- Local Institution
-
Pori, Финляндия, 28120
- Local Institution
-
Tampere, Финляндия, 33100
- Local Institution
-
-
-
-
-
Amiens Cedex 1, Франция, 80054
- Local Institution
-
Bordeaux Cedex, Франция, 33075
- Local Institution
-
Brest, Франция, 29609
- Local Institution
-
Grenoble Cedex 09, Франция, 38043
- Local Institution
-
La Seyne Sur Mer, Франция, 83500
- Local Institution
-
Paris Cedex 18, Франция, 75018
- Local Institution
-
Six Fours Les Plages, Франция, 83140
- Local Institution
-
-
-
-
-
Boskovice, Чехия, 680 21
- Local Institution
-
Brno, Чехия, 625 00
- Local Institution
-
Brno-Malomerice, Чехия, 614 00
- Local Institution
-
Ivancice, Чехия, 664 91
- Local Institution
-
Kladno, Чехия, 272 59
- Local Institution
-
Litomysl, Чехия, 570 14
- Local Institution
-
Mestec Kralove, Чехия, 289 03
- Local Institution
-
Ostrava, Чехия, 70852
- Local Institution
-
Prague 13, Чехия, 158 00
- Local Institution
-
Prague 2, Чехия, 128 08
- Local Institution
-
Pribram, Чехия, 261 01
- Local Institution
-
Usti Nad Orlici, Чехия, 562 18
- Local Institution
-
-
-
-
LOS Lagos
-
Osorno, LOS Lagos, Чили, 5311089
- Local Institution
-
Osorno, LOS Lagos, Чили, 5311523
- Local Institution
-
-
Metropolitana
-
Santiago, Metropolitana, Чили, 7500520
- Local Institution
-
Santiago, Metropolitana, Чили, 7500922
- Local Institution
-
Santiago, Metropolitana, Чили, 8330074
- Local Institution
-
-
Region DE LA Araucania
-
Temuco, Region DE LA Araucania, Чили, 4781176
- Local Institution
-
-
Region De La Araucania
-
Temuco, Region De La Araucania, Чили, 4781156
- Local Institution
-
-
Valparaiso
-
Temuco, Valparaiso, Чили, 4781173
- Local Institution
-
Vina Del Mar, Valparaiso, Чили, 2570017
- Local Institution
-
-
-
-
-
Baden, Швейцария, 5404
- Local Institution
-
Bern, Швейцария, 3010
- Local Institution
-
-
-
-
-
Goteberg, Швеция, 413 45
- Local Institution
-
Helsingborg, Швеция, 251 87
- Local Institution
-
Linkoping, Швеция, 581 85
- Local Institution
-
Lund, Швеция, 222 21
- Local Institution
-
Orebro, Швеция, 70185
- Local Institution
-
Orebro, Швеция, 701 85
- Local Institution
-
Skelleftea, Швеция, 931 86
- Local Institution
-
Stockholm, Швеция, 141 86
- Local Institution
-
Stockholm, Швеция, 171 76
- Local Institution
-
Stockholm, Швеция, 111 57
- Local Institution
-
Stockholm, Швеция, 118 83
- Local Institution
-
Stockholm, Швеция, 111 35
- Local Institution
-
Uppsala, Швеция, 751 85
- Local Institution
-
Vaxjo, Швеция, 351 85
- Local Institution
-
-
-
-
Bloemfontein
-
Westdene, Bloemfontein, Южная Африка, 9301
- Local Institution
-
-
Cape Town
-
Observatory, Cape Town, Южная Африка, 7925
- Local Institution
-
-
Gauteng
-
Pretoria, Gauteng, Южная Африка, 0084
- Local Institution
-
Pretoria, Gauteng, Южная Африка, 0132
- Local Institution
-
-
KWA ZULU Natal
-
Richards Bay, KWA ZULU Natal, Южная Африка, 3900
- Local Institution
-
-
Western CAPE
-
Bellville Cape Town, Western CAPE, Южная Африка, 7530
- Local Institution
-
George, Western CAPE, Южная Африка, 6529
- Local Institution
-
Parow, Western CAPE, Южная Африка, 7505
- Local Institution
-
Somerset West, Western CAPE, Южная Африка, 7130
- Local Institution
-
Worcester, Western CAPE, Южная Африка, 6850
- Local Institution
-
-
-
-
-
Fukui, Япония, 9100067
- Local Institution
-
Kagoshima, Япония, 8920822
- Local Institution
-
Kyoto, Япония, 6168152
- Local Institution
-
Nagasaki, Япония, 852-8102
- Local Institution
-
Oita, Япония, 8700033
- Local Institution
-
Osaka, Япония, 558-8558
- Local Institution
-
Osaka, Япония, 551-0032
- Local Institution
-
Osaka, Япония, 5510032
- Local Institution
-
Saga, Япония, 8490917
- Local Institution
-
-
Fukuoka
-
Itoshima City, Fukuoka, Япония, 819-1104
- Local Institution
-
Kurume, Fukuoka, Япония, 8390863
- Local Institution
-
Ohkawa-City, Fukuoka, Япония, 8310016
- Local Institution
-
-
Fukushima
-
Shirakawa City, Fukushima, Япония, 961-0005
- Local Institution
-
-
Gunma
-
Takasaki City, Gunma, Япония, 3700829
- Local Institution
-
-
Hokkaido
-
Asahikawa-Shi, Hokkaido, Япония, 0788214
- Local Institution
-
Katou-Gun, Hokkaido, Япония, 0800111
- Local Institution
-
Katou-gun, Hokkaido, Япония, 080111
- Local Institution
-
Sapporo-Shi, Hokkaido, Япония, 0028043
- Local Institution
-
Tomakomai-Shi, Hokkaido, Япония, 002-8043
- Local Institution
-
Tomakomai-shi, Hokkaido, Япония, 0028043
- Local Institution
-
Yubari, Hokkaido, Япония, 0680402
- Local Institution
-
-
Hyogo
-
Kobe, Hyogo, Япония, 6540026
- Local Institution
-
-
Kagoshima Prefecture
-
Izumi City, Kagoshima Prefecture, Япония, 8990131
- Local Institution
-
-
Kanagawa
-
Isehara, Kanagawa, Япония, 2591193
- Local Institution
-
Yokohama, Kanagawa, Япония, 2458575
- Local Institution
-
Yokohama City, Kanagawa, Япония, 2278501
- Local Institution
-
Yokosuka, Kanagawa, Япония, 2388567
- Local Institution
-
-
Miyagi
-
Sendai City, Miyagi, Япония, 983-8520
- Local Institution
-
-
Nara
-
Nara City, Nara, Япония, 630-8305
- Local Institution
-
-
Osaka
-
Izumi City, Osaka, Япония, 594-0071
- Local Institution
-
Osaka City, Osaka, Япония, 5330022
- Local Institution
-
Osaka-Shi, Osaka, Япония, 540-0006
- Local Institution
-
Osaka-shi, Osaka, Япония, 5400006
- Local Institution
-
Suita-City, Osaka, Япония, 5658565
- Local Institution
-
Takatsuki City, Osaka, Япония, 5690852
- Local Institution
-
Yao, Osaka, Япония, 5810036
- Local Institution
-
-
Saga
-
Saga City, Saga, Япония, 840-8571
- Local Institution
-
Saga City, Saga, Япония, 849-8501
- Local Institution
-
-
Saitama
-
Kasukabe-Shi, Saitama, Япония, 344-0035
- Local Institution
-
Kasukabe-shi, Saitama, Япония, 3440035
- Local Institution
-
-
Tokyo
-
Itabashi-Ku, Tokyo, Япония, 173-0015
- Local Institution
-
Itabashi-ku, Tokyo, Япония, 1730015
- Local Institution
-
Meguro-Ku, Tokyo, Япония, 153-8515
- Local Institution
-
Meguro-ku, Tokyo, Япония, 1538515
- Local Institution
-
Shinagawa-Ku, Tokyo, Япония, 1428666
- Local Institution
-
-
Toyama
-
Toyama City, Toyama, Япония, 9308550
- Local Institution
-
-
Yamaguchi
-
Iwakuni, Yamaguchi, Япония, 7400021
- Local Institution
-
-
Критерии участия
Исследователи ищут людей, которые соответствуют определенному описанию, называемому критериям приемлемости. Некоторыми примерами этих критериев являются общее состояние здоровья человека или предшествующее лечение.
Критерии приемлемости
Возраст, подходящий для обучения
- Ребенок
- Взрослый
- Пожилой взрослый
Принимает здоровых добровольцев
Нет
Полы, имеющие право на обучение
Все
Описание
Inclusion Criteria:
- Males and females ≥ 18 yrs with atrial fibrillation (AF) and one or more of the following risk factors for stroke:
- Age ≥ 75, previous stroke
- transient ischemic attack (TIA) or Systemic Embolism (SE)
- Symptomatic congestive heart failure or left ventricular dysfunction with left ventricular ejection fraction (LVEF) ≤ 40%
- Diabetes mellitus or hypertension requiring pharmacological treatment
Учебный план
В этом разделе представлена подробная информация о плане исследования, в том числе о том, как планируется исследование и что оно измеряет.
Как устроено исследование?
Детали дизайна
- Основная цель: Профилактика
- Распределение: Рандомизированный
- Интервенционная модель: Параллельное назначение
- Маскировка: Двойной
Оружие и интервенции
Группа участников / Армия |
Вмешательство/лечение |
|---|---|
|
Экспериментальный: 2
|
Oral tablets, 5.0 mg or 2.5 mg, twice daily
Другие имена:
|
|
Активный компаратор: 1
|
Oral tablets, 2.0 mg, adjusted to an INR of 2.5 (range 2.0 to 3.0)
Другие имена:
|
Что измеряет исследование?
Первичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Number of Participants With First Event of Ischemic/Unspecified Stroke, Hemorrhagic Stroke, or Systemic Embolism (SE) During the Intended Treatment Period
Временное ограничение: Time to first event in "Intended Treatment Period": started on day of randomization, ended at efficacy cut-off date (date target number of primary efficacy events [448] was expected to have occurred; set to 30-Jan-2011, prior to unblinding).
|
All suspected efficacy events were adjudicated by the Central Events Committee (CEC).
Diagnosis of stroke=the nontraumatic focal neurological deficit lasting at least 24 hours, and includes ischemic stroke, hemorrhagic stroke, ischemic stroke with hemorrhagic conversion, stroke of uncertain type, and retinal ischemic event (embolism, infarction).
Diagnosis of SE=clinical history consistent with an acute loss of blood flow to a peripheral artery (or arteries), supported by evidence of embolism from surgical specimens, autopsy, angiography, vascular imaging, or other objective testing.
|
Time to first event in "Intended Treatment Period": started on day of randomization, ended at efficacy cut-off date (date target number of primary efficacy events [448] was expected to have occurred; set to 30-Jan-2011, prior to unblinding).
|
|
Rate of Adjudicated Stroke or Systemic Embolism (SE) During the Intended Treatment Period
Временное ограничение: "Intended Treatment Period" started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding).
|
Rate=Number of adjudicated stroke or SE events per 100 patient years.
Diagnosis of stroke=the nontraumatic focal neurological deficit lasting at least 24 hours, and includes ischemic stroke, hemorrhagic stroke, ischemic stroke with hemorrhagic conversion, stroke of uncertain type, and retinal ischemic event (embolism, infarction).
Diagnosis of SE=clinical history consistent with an acute loss of blood flow to a peripheral artery (or arteries), supported by evidence of embolism from surgical specimens, autopsy, angiography, vascular imaging, or other objective testing.
|
"Intended Treatment Period" started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding).
|
Вторичные показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Number of Participants With Event of Major (International Society on Thrombosis and Hemostasis [ISTH]) Bleeding During Treatment Period
Временное ограничение: "Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
ISTH Bleeding Criteria: Major bleeding=a bleeding event that was: clinically overt bleeding accompanied by a decrease in hemoglobin (Hgb) of 2 g/dL or more, and/or a transfusion of 2 or more units of packed red blood cells; bleeding that occurred in at least 1 of the following critical sites: intracranial, intraspinal, intraocular (within the corpus of the eye; a conjunctival bleed is not an intraocular bleed), pericardial, intra-articular, intramuscular with compartment syndrome, and retroperitoneal; bleeding that was fatal.
|
"Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
|
Rate of Adjudicated Major (ISTH) Bleed Events During Treatment Period
Временное ограничение: "Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
Rate=number of adjudicated major (ISTH) bleed events per 100 patient years.
ISTH Bleeding Criteria: Major bleeding=a bleeding event that was: clinically overt bleeding accompanied by a decrease in hemoglobin (Hgb) of 2 g/dL or more and/or a transfusion of 2 or more units of packed red blood cells; bleeding that occurred in at least 1 of the following sites: intracranial, intraspinal, intraocular (within the corpus of the eye; a conjunctival bleed is not an intraocular bleed), pericardial, intra-articular, intramuscular with compartment syndrome, and retroperitoneal; bleeding that was fatal.
|
"Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
|
Number of Participants With Events of All-Cause Death During the Intended Treatment Period
Временное ограничение: "Intended Treatment Period" started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding).
|
Death was defined as all-cause mortality.
All unobserved deaths were assumed to be cardiovascular in nature unless a non-cardiovascular cause could be clearly provided.
Cardiovascular=deaths due to ischemic and hemorrhagic stroke, SE, myocardial infarction (MI), sudden death, heart failure, other cardiovascular, and unobserved deaths.
Non-cardiovascular=all deaths due to a clearly documented non-cardiovascular cause (further classified into the categories: bleeding, study drug toxicity other than bleeding, malignancy, infection, trauma, and pulmonary causes of death).
|
"Intended Treatment Period" started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding).
|
|
Rate of Adjudicated All-Cause Death During the Intended Treatment Period
Временное ограничение: "Intended Treatment Period" started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding).
|
All unobserved deaths were assumed to be cardiovascular in nature unless a non-cardiovascular cause could be clearly provided.
Cardiovascular=deaths due to ischemic and hemorrhagic stroke, SE, MI, sudden death, heart failure, other cardiovascular, and unobserved deaths.
Non-cardiovascular=all deaths due to a clearly documented non-cardiovascular cause (further classified into the categories: bleeding, study drug toxicity other than bleeding, malignancy, infection, trauma, and pulmonary causes of death).
|
"Intended Treatment Period" started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding).
|
|
Rate of Ischemic or Unspecified Stroke, Hemorrhagic Stroke, Systemic Embolism (SE), and Myocardial Infarction (MI) (as Individual Endpoints) During the Intended Treatment Period
Временное ограничение: "Intended Treatment Period" started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding).
|
Diagnosis for an acute or evolving MI=elevation of creatine kinase-MB isoenzyme (CK-MB) or Troponin T or I ≥ 2 × the upper limit of normal (ULN), or if no CK-MB or troponin values are available, a total CK ≥ 2×ULN, or new, significant (≥0.04 s) Q waves in ≥2 contiguous leads.
For descriptions of Stroke and SE, see Outcome Measure 1.
|
"Intended Treatment Period" started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding).
|
|
Rate of Ischemic or Unspecified Stroke, Hemorrhagic Stroke, Systemic Embolism (SE), Myocardial Infarction (MI) and All-Cause Death (ACD) (as Composite Endpoints) During the Intended Treatment Period
Временное ограничение: "Intended Treatment Period" started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding).
|
Diagnosis for an acute or evolving MI=elevation of CK-MB or Troponin T or I ≥ 2 × the ULN, or if no CK-MB or troponin values are available, a total CK ≥ 2×ULN, or new, significant (≥0.04 s) Q waves in ≥2 contiguous leads.
For descriptions of Stroke and SE, see Outcome Measure 1.
For description of ACD, see Outcome Measure 5.
|
"Intended Treatment Period" started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding).
|
|
Number of Warfarin/Vitamin K Antagonist (VKA) Naive Participants With Composite Stroke / Systemic Embolism (SE) / Major Bleeding During the Intended Treatment Period
Временное ограничение: "Intended Treatment Period" started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding).
|
For descriptions of Stroke and SE, see Outcome Measure 1.
For description of Major bleeding, see Outcome Measure 3.
|
"Intended Treatment Period" started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding).
|
|
Rate of Composite Stroke / Systemic Embolism / Major Bleeding in Warfarin/Vitamin K Antagonist (VKA) Naive Participants During the Intended Treatment Period
Временное ограничение: "Intended Treatment Period" started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding).
|
"Intended Treatment Period" started on the day of randomization and ended at the efficacy cut-off date (date on which it was expected that the target number of primary efficacy events [448] would have occurred; set to 30-Jan-2011, prior to unblinding).
|
|
|
Number of Participants With Events of Major or Clinically Relevant Nonmajor (CRNM) Bleed During Treatment Period
Временное ограничение: "Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
Major bleeding=bleeding that is clinically overt and that either resulted in a decrease in hemoglobin of 2 g/dL or more over a 24-hour period, led to a transfusion of 2 or more units of packed red blood cells, occurred in a critical site, or led to death.
CRNM bleeding=bleeding that is clinically overt, that satisfies none of the additional criteria required for the event to be adjudicated as a major bleeding event, that led to either hospital admission for bleeding, physician-guided medical or surgical treatment for bleeding, or a change in antithrombotic therapy.
|
"Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
|
Rate of Events of Major or Clinically Relevant Non-Major (CRNM) Bleed During Treatment Period
Временное ограничение: "Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
Rate=number of major or CRNM bleed events per 100 patient years.
Major=clinically overt and either 1) resulted in a decrease in hemoglobin of 2 g/dL or more, or 2) led to a transfusion of 2 or more units of packed red blood cells, or 3) occurred in a critical site, or 4) led to death.
CRNM bleeding=clinically overt, but satisfied no additional criteria required to be adjudicated as a major bleeding event, and led to either 1) hospital admission for bleeding or 2) physician guided medical or surgical treatment for bleeding or 3) a change in antithrombotic therapy.
|
"Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
|
Number of Participants With All Bleeding Events During Treatment Period
Временное ограничение: "Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
All bleeding events include major bleeding, CRNM bleeding (see Outcome Measure 12 Description for definitions), plus events of minor bleeding and fatal bleeding.
Minor bleeding: All acute clinically overt bleeding events not meeting the criteria for either major bleeding or clinically relevant non-major bleeding will be classified as minor bleeding.
Fatal bleeding is defined as a bleeding event that the Clinical Events Committee determines is the primary cause of death or contributes directly to death.
|
"Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
|
Rate of All Bleeding Events During Treatment Period
Временное ограничение: "Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
Rate=number of all bleeding events per 100 patient years.
"All bleeding events" include major bleeding, CRNM bleeding (see Outcome Measure 12 Description for definitions), plus events of minor bleeding and fatal bleeding.
Minor bleeding: All acute clinically overt bleeding events not meeting the criteria for either major bleeding or clinically relevant non-major bleeding will be classified as minor bleeding.
Fatal bleeding is defined as a bleeding event that the Clinical Events Committee determines is the primary cause of death or contributes directly to death.
|
"Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
Другие показатели результатов
Мера результата |
Мера Описание |
Временное ограничение |
|---|---|---|
|
Number of Participants With Adverse Events (AEs), Bleeding AEs, Serious Adverse Events (SAEs), Discontinuations Due to AEs, or Deaths During the Treatment Period
Временное ограничение: "Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
AE: all SAEs or AEs with onset from first dose through 2 days (AEs) or 30 days (SAEs) after the last dose of blinded study drug (BSD).
SAE: all SAEs with onset from first dose through 30 days after the last dose of BSD.
Bleeding AE: all serious or non-serious bleeding-related AEs with onset from first dose through 2 days after the last dose of BSD.
Discontinuations due to AE: all SAEs or AEs with onset from first dose of BSD and with action taken=drug discontinued.
Deaths: all deaths occurring from first dose through 30 days after the last dose of BSD.
|
"Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
|
Rate of Adjudicated Bleeding Endpoints Per Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) During the Treatment Period
Временное ограничение: "Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
Rate=number of adjudicated GUSTO bleeding events per 100 patient years.
GUSTO Bleeding Criteria: GUSTO severe (or life-threatening) bleeding: either intracranial hemorrhage or bleeding that causes hemodynamic compromise and requires intervention.
GUSTO moderate bleeding: bleeding that requires blood transfusion but does not result in hemodynamic compromise.
|
"Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
|
Rate of Adjudicated Bleeding Endpoints Per Thrombolysis in Myocardial Infarction (TIMI) During the Treatment Period
Временное ограничение: "Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
Rate=number of adjudicated TIMI bleeding events per 100 patient years.
TIMI Bleeding Criteria: Major bleeding=Intracranial bleeding and/or clinically overt bleeding associated with ≥5 gm/dL fall in Hgb or 15% fall in hematocrit (Hct) from baseline, accounting for transfusions.
Minor bleeding=Clinically overt bleeding associated with ≥3 gm/dL fall in Hgb or a ≥10% fall in Hct from baseline, accounting for transfusions.
|
"Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
|
Number of Participants With Net-Clinical Benefit During Treatment Period
Временное ограничение: "Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
Net-Clinical Benefit = Composite of stroke, systemic embolism and ISTH major bleeding.
|
"Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
|
Rate of Net-Clinical Benefit During Treatment Period
Временное ограничение: "Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
Rate=number of events of net-clinical benefit per 100 patient years.
Net-Clinical Benefit = Composite of stroke, systemic embolism and ISTH major bleeding
|
"Treatment Period" started with first dose of blinded study drug and ended 2 days after the last dose of blinded study drug. Mean duration of exposure to double-blind study drug was 1.7 years in each treatment group.
|
Соавторы и исследователи
Здесь вы найдете людей и организации, участвующие в этом исследовании.
Спонсор
Публикации и полезные ссылки
Лицо, ответственное за внесение сведений об исследовании, добровольно предоставляет эти публикации. Это может быть что угодно, связанное с исследованием.
Общие публикации
- Jamieson MJ, Byon W, Dettloff RW, Crawford M, Gargalovic PS, Merali SJ, Onorato J, Quintero AJ, Russ C. Apixaban Use in Obese Patients: A Review of the Pharmacokinetic, Interventional, and Observational Study Data. Am J Cardiovasc Drugs. 2022 Nov;22(6):615-631. doi: 10.1007/s40256-022-00524-x. Epub 2022 May 16.
- Pol T, Hijazi Z, Lindback J, Oldgren J, Alexander JH, Connolly SJ, Eikelboom JW, Ezekowitz MD, Granger CB, Lopes RD, Yusuf S, Siegbahn A, Wallentin L. Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation. Cardiovasc Res. 2022 Jul 20;118(9):2112-2123. doi: 10.1093/cvr/cvab262.
- Pol T, Hijazi Z, Lindback J, Alexander JH, Bahit MC, De Caterina R, Eikelboom JW, Ezekowitz MD, Gersh BJ, Granger CB, Hylek EM, Lopes R, Siegbahn A, Wallentin L. Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas. Open Heart. 2021 Mar;8(1):e001471. doi: 10.1136/openhrt-2020-001471.
- Hijazi Z, Wallentin L, Lindback J, Alexander JH, Connolly SJ, Eikelboom JW, Ezekowitz MD, Granger CB, Lopes RD, Pol T, Yusuf S, Oldgren J, Siegbahn A. Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation. J Am Heart Assoc. 2020 Dec 15;9(24):e018984. doi: 10.1161/JAHA.120.018984. Epub 2020 Dec 9.
- Wallentin L, Lindback J, Eriksson N, Hijazi Z, Eikelboom JW, Ezekowitz MD, Granger CB, Lopes RD, Yusuf S, Oldgren J, Siegbahn A. Angiotensin-converting enzyme 2 (ACE2) levels in relation to risk factors for COVID-19 in two large cohorts of patients with atrial fibrillation. Eur Heart J. 2020 Nov 1;41(41):4037-4046. doi: 10.1093/eurheartj/ehaa697.
- Hijazi Z, Oldgren J, Lindback J, Alexander JH, Connolly SJ, Eikelboom JW, Ezekowitz MD, Held C, Hylek EM, Lopes RD, Yusuf S, Granger CB, Siegbahn A, Wallentin L; ARISTOTLE and RE-LY Investigators. A biomarker-based risk score to predict death in patients with atrial fibrillation: the ABC (age, biomarkers, clinical history) death risk score. Eur Heart J. 2018 Feb 7;39(6):477-485. doi: 10.1093/eurheartj/ehx584.
- Oldgren J, Hijazi Z, Lindback J, Alexander JH, Connolly SJ, Eikelboom JW, Ezekowitz MD, Granger CB, Hylek EM, Lopes RD, Siegbahn A, Yusuf S, Wallentin L; RE-LY and ARISTOTLE Investigators. Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation. Circulation. 2016 Nov 29;134(22):1697-1707. doi: 10.1161/CIRCULATIONAHA.116.022802. Epub 2016 Aug 28.
- Hijazi Z, Oldgren J, Lindback J, Alexander JH, Connolly SJ, Eikelboom JW, Ezekowitz MD, Held C, Hylek EM, Lopes RD, Siegbahn A, Yusuf S, Granger CB, Wallentin L; ARISTOTLE and RE-LY Investigators. The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study. Lancet. 2016 Jun 4;387(10035):2302-2311. doi: 10.1016/S0140-6736(16)00741-8. Epub 2016 Apr 4.
- Hijazi Z, Lindback J, Alexander JH, Hanna M, Held C, Hylek EM, Lopes RD, Oldgren J, Siegbahn A, Stewart RA, White HD, Granger CB, Wallentin L; ARISTOTLE and STABILITY Investigators. The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation. Eur Heart J. 2016 May 21;37(20):1582-90. doi: 10.1093/eurheartj/ehw054. Epub 2016 Feb 25.
- Hijazi Z, Granger CB, Hohnloser SH, Westerbergh J, Lindback J, Alexander JH, Keltai M, Parkhomenko A, Lopez-Sendon JL, Lopes RD, Siegbahn A, Wallentin L. Association of Different Estimates of Renal Function With Cardiovascular Mortality and Bleeding in Atrial Fibrillation. J Am Heart Assoc. 2020 Sep 15;9(18):e017155. doi: 10.1161/JAHA.120.017155. Epub 2020 Aug 31.
- Zeitouni M, Giczewska A, Alexander JH. Reply: Specifics of Dose Modification in ARISTOTLE. J Am Coll Cardiol. 2020 Jul 7;76(1):128-129. doi: 10.1016/j.jacc.2020.05.013. No abstract available.
- Rosjo H, Hijazi Z, Omland T, Westerbergh J, Lyngbakken MN, Alexander JH, Gersh BJ, Granger CB, Hylek EM, Lopes RD, Siegbahn A, Wallentin L. Cardiac troponin is associated with cardiac outcomes in men and women with atrial fibrillation, insights from the ARISTOTLE trial. J Intern Med. 2020 Aug;288(2):248-259. doi: 10.1111/joim.13072. Epub 2020 May 18.
- Zeitouni M, Giczewska A, Lopes RD, Wojdyla DM, Christersson C, Siegbahn A, De Caterina R, Steg PG, Granger CB, Wallentin L, Alexander JH; ARISTOTLE Investigators. Clinical and Pharmacological Effects of Apixaban Dose Adjustment in the ARISTOTLE Trial. J Am Coll Cardiol. 2020 Mar 17;75(10):1145-1155. doi: 10.1016/j.jacc.2019.12.060.
- Stanifer JW, Pokorney SD, Chertow GM, Hohnloser SH, Wojdyla DM, Garonzik S, Byon W, Hijazi Z, Lopes RD, Alexander JH, Wallentin L, Granger CB. Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease. Circulation. 2020 Apr 28;141(17):1384-1392. doi: 10.1161/CIRCULATIONAHA.119.044059. Epub 2020 Mar 12.
- Garcia DA, Fisher DA, Mulder H, Wruck L, De Caterina R, Halvorsen S, Granger CB, Held C, Wallentin L, Alexander JH, Lopes RD. Gastrointestinal bleeding in patients with atrial fibrillation treated with Apixaban or warfarin: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. Am Heart J. 2020 Mar;221:1-8. doi: 10.1016/j.ahj.2019.10.013. Epub 2019 Oct 31.
- Dalgaard F, Mulder H, Wojdyla DM, Lopes RD, Held C, Alexander JH, De Caterina R, Washam JB, Hylek EM, Garcia DA, Gersh BJ, Wallentin L, Granger CB, Al-Khatib SM. Patients With Atrial Fibrillation Taking Nonsteroidal Anti-Inflammatory Drugs and Oral Anticoagulants in the ARISTOTLE Trial. Circulation. 2020 Jan 7;141(1):10-20. doi: 10.1161/CIRCULATIONAHA.119.041296. Epub 2019 Nov 21.
- Goldstein SA, Green J, Huber K, Wojdyla DM, Lopes RD, Alexander JH, Vinereanu D, Wallentin L, Granger CB, Al-Khatib SM. Characteristics and Outcomes of Atrial Fibrillation in Patients With Thyroid Disease (from the ARISTOTLE Trial). Am J Cardiol. 2019 Nov 1;124(9):1406-1412. doi: 10.1016/j.amjcard.2019.07.046. Epub 2019 Aug 7.
- Guimaraes PO, Pokorney SD, Lopes RD, Wojdyla DM, Gersh BJ, Giczewska A, Carnicelli A, Lewis BS, Hanna M, Wallentin L, Vinereanu D, Alexander JH, Granger CB. Efficacy and safety of apixaban vs warfarin in patients with atrial fibrillation and prior bioprosthetic valve replacement or valve repair: Insights from the ARISTOTLE trial. Clin Cardiol. 2019 May;42(5):568-571. doi: 10.1002/clc.23178. Epub 2019 Apr 9.
- Washam JB, Hohnloser SH, Lopes RD, Wojdyla DM, Vinereanu D, Alexander JH, Gersh BJ, Hanna M, Horowitz J, Hylek EM, Xavier D, Verheugt FWA, Wallentin L, Granger CB; ARISTOTLE Committees and Investigators. Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial. J Thromb Thrombolysis. 2019 Apr;47(3):345-352. doi: 10.1007/s11239-019-01823-y.
- Hohnloser SH, Fudim M, Alexander JH, Wojdyla DM, Ezekowitz JA, Hanna M, Atar D, Hijazi Z, Bahit MC, Al-Khatib SM, Lopez-Sendon JL, Wallentin L, Granger CB, Lopes RD. Efficacy and Safety of Apixaban Versus Warfarin in Patients With Atrial Fibrillation and Extremes in Body Weight. Circulation. 2019 May 14;139(20):2292-2300. doi: 10.1161/CIRCULATIONAHA.118.037955.
- Alexander KP, Brouwer MA, Mulder H, Vinereanu D, Lopes RD, Proietti M, Al-Khatib SM, Hijazi Z, Halvorsen S, Hylek EM, Verheugt FWA, Alexander JH, Wallentin L, Granger CB; ARISTOTLE Investigators. Outcomes of apixaban versus warfarin in patients with atrial fibrillation and multi-morbidity: Insights from the ARISTOTLE trial. Am Heart J. 2019 Feb;208:123-131. doi: 10.1016/j.ahj.2018.09.017. Epub 2018 Nov 22.
- Sandhu RK, Ezekowitz JA, Hijazi Z, Westerbergh J, Aulin J, Alexander JH, Granger CB, Halvorsen S, Hanna MS, Lopes RD, Siegbahn A, Wallentin L. Obesity paradox on outcome in atrial fibrillation maintained even considering the prognostic influence of biomarkers: insights from the ARISTOTLE trial. Open Heart. 2018 Nov 1;5(2):e000908. doi: 10.1136/openhrt-2018-000908. eCollection 2018.
- Christersson C, Wallentin L, Andersson U, Alexander JH, Alings M, De Caterina R, Gersh BJ, Granger CB, Halvorsen S, Hanna M, Huber K, Hylek EM, Lopes RD, Oh BH, Siegbahn A. Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation. Heart. 2019 Feb;105(3):235-242. doi: 10.1136/heartjnl-2018-313351. Epub 2018 Sep 12.
- Horowitz JD, De Caterina R, Heresztyn T, Alexander JH, Andersson U, Lopes RD, Steg PG, Hylek EM, Mohan P, Hanna M, Jansky P, Granger CB, Wallentin L; ARISTOTLE Investigators. Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation: An ARISTOTLE Substudy. J Am Coll Cardiol. 2018 Aug 14;72(7):721-733. doi: 10.1016/j.jacc.2018.05.058.
- Sharma A, Hijazi Z, Andersson U, Al-Khatib SM, Lopes RD, Alexander JH, Held C, Hylek EM, Leonardi S, Hanna M, Ezekowitz JA, Siegbahn A, Granger CB, Wallentin L. Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation. Circulation. 2018 Oct 16;138(16):1666-1676. doi: 10.1161/CIRCULATIONAHA.118.034125.
- Kopin D, Jones WS, Sherwood MW, Wojdyla DM, Wallentin L, Lewis BS, Verheugt FWA, Vinereanu D, Bahit MC, Halvorsen S, Huber K, Parkhomenko A, Granger CB, Lopes RD, Alexander JH. Percutaneous coronary intervention and antiplatelet therapy in patients with atrial fibrillation receiving apixaban or warfarin: Insights from the ARISTOTLE trial. Am Heart J. 2018 Mar;197:133-141. doi: 10.1016/j.ahj.2017.11.005. Epub 2017 Nov 10.
- Pol T, Held C, Westerbergh J, Lindback J, Alexander JH, Alings M, Erol C, Goto S, Halvorsen S, Huber K, Hanna M, Lopes RD, Ruzyllo W, Granger CB, Hijazi Z. Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial. J Am Heart Assoc. 2018 Feb 1;7(3):e007444. doi: 10.1161/JAHA.117.007444.
- Goto S, Merrill P, Wallentin L, Wojdyla DM, Hanna M, Avezum A, Easton JD, Harjola VP, Huber K, Lewis BS, Parkhomenko A, Zhu J, Granger CB, Lopes RD, Alexander JH. Antithrombotic therapy use and clinical outcomes following thrombo-embolic events in patients with atrial fibrillation: insights from ARISTOTLE. Eur Heart J Cardiovasc Pharmacother. 2018 Apr 1;4(2):75-81. doi: 10.1093/ehjcvp/pvy002.
- Vinereanu D, Wang A, Mulder H, Lopes RD, Jansky P, Lewis BS, Gersh BJ, Avezum A, Hanna M, Held C, Wallentin L, Granger CB, Alexander JH. Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve disease. Heart. 2018 Aug;104(15):1292-1299. doi: 10.1136/heartjnl-2017-312272. Epub 2018 Jan 19.
- Rao MP, Vinereanu D, Wojdyla DM, Alexander JH, Atar D, Hylek EM, Hanna M, Wallentin L, Lopes RD, Gersh BJ, Granger CB; Apixaban for Reduction in Stroke Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Investigators. Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial. Am J Med. 2018 Mar;131(3):269-275.e2. doi: 10.1016/j.amjmed.2017.10.036. Epub 2017 Nov 6.
- Vinereanu D, Lopes RD, Mulder H, Gersh BJ, Hanna M, de Barros E Silva PGM, Atar D, Wallentin L, Granger CB, Alexander JH; ARISTOTLE Investigators. Echocardiographic Risk Factors for Stroke and Outcomes in Patients With Atrial Fibrillation Anticoagulated With Apixaban or Warfarin. Stroke. 2017 Dec;48(12):3266-3273. doi: 10.1161/STROKEAHA.117.017574. Epub 2017 Oct 31.
- Hijazi Z, Lindahl B, Oldgren J, Andersson U, Lindback J, Granger CB, Alexander JH, Gersh BJ, Hanna M, Harjola VP, Hylek EM, Lopes RD, Siegbahn A, Wallentin L. Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time. J Am Heart Assoc. 2017 Jun 23;6(6):e004851. doi: 10.1161/JAHA.116.004851.
- Lopes RD, Guimaraes PO, Kolls BJ, Wojdyla DM, Bushnell CD, Hanna M, Easton JD, Thomas L, Wallentin L, Al-Khatib SM, Held C, Gabriel Melo de Barros E Silva P, Alexander JH, Granger CB, Diener HC. Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy. Blood. 2017 Jun 1;129(22):2980-2987. doi: 10.1182/blood-2016-08-731638. Epub 2017 Mar 29.
- Cowper PA, Sheng S, Lopes RD, Anstrom KJ, Stafford JA, Davidson-Ray L, Al-Khatib SM, Ansell J, Dorian P, Husted S, McMurray JJV, Steg PG, Alexander JH, Wallentin L, Granger CB, Mark DB. Economic Analysis of Apixaban Therapy for Patients With Atrial Fibrillation From a US Perspective: Results From the ARISTOTLE Randomized Clinical Trial. JAMA Cardiol. 2017 May 1;2(5):525-534. doi: 10.1001/jamacardio.2017.0065.
- Hu PT, Lopes RD, Stevens SR, Wallentin L, Thomas L, Alexander JH, Hanna M, Lewis BS, Verheugt FW, Granger CB, Jones WS. Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and Peripheral Artery Disease: Insights From the ARISTOTLE Trial. J Am Heart Assoc. 2017 Jan 17;6(1):e004699. doi: 10.1161/JAHA.116.004699.
- Bahit MC, Lopes RD, Wojdyla DM, Held C, Hanna M, Vinereanu D, Hylek EM, Verheugt F, Goto S, Alexander JH, Wallentin L, Granger CB. Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation. Heart. 2017 Apr;103(8):623-628. doi: 10.1136/heartjnl-2016-309901. Epub 2016 Oct 24.
- Alexander JH, Andersson U, Lopes RD, Hijazi Z, Hohnloser SH, Ezekowitz JA, Halvorsen S, Hanna M, Commerford P, Ruzyllo W, Huber K, Al-Khatib SM, Granger CB, Wallentin L; Apixaban for Reduction of Stroke and Other Thromboembolic Complications in Atrial Fibrillation (ARISTOTLE) Investigators. Apixaban 5 mg Twice Daily and Clinical Outcomes in Patients With Atrial Fibrillation and Advanced Age, Low Body Weight, or High Creatinine: A Secondary Analysis of a Randomized Clinical Trial. JAMA Cardiol. 2016 Sep 1;1(6):673-81. doi: 10.1001/jamacardio.2016.1829.
- Hijazi Z, Hohnloser SH, Andersson U, Alexander JH, Hanna M, Keltai M, Parkhomenko A, Lopez-Sendon JL, Lopes RD, Siegbahn A, Granger CB, Wallentin L. Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation in Relation to Renal Function Over Time: Insights From the ARISTOTLE Randomized Clinical Trial. JAMA Cardiol. 2016 Jul 1;1(4):451-60. doi: 10.1001/jamacardio.2016.1170.
- Jaspers Focks J, Brouwer MA, Wojdyla DM, Thomas L, Lopes RD, Washam JB, Lanas F, Xavier D, Husted S, Wallentin L, Alexander JH, Granger CB, Verheugt FW. Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial. BMJ. 2016 Jun 15;353:i2868. doi: 10.1136/bmj.i2868.
- Hijazi Z, Aulin J, Andersson U, Alexander JH, Gersh B, Granger CB, Hanna M, Horowitz J, Hylek EM, Lopes RD, Siegbahn A, Wallentin L; ARISTOTLE Investigators. Biomarkers of inflammation and risk of cardiovascular events in anticoagulated patients with atrial fibrillation. Heart. 2016 Apr;102(7):508-17. doi: 10.1136/heartjnl-2015-308887. Epub 2016 Feb 2.
- Rao MP, Halvorsen S, Wojdyla D, Thomas L, Alexander JH, Hylek EM, Hanna M, Bahit MC, Lopes RD, De Caterina R, Erol C, Goto S, Lanas F, Lewis BS, Husted S, Gersh BJ, Wallentin L, Granger CB; Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Steering Committee and Investigators. Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial. J Am Heart Assoc. 2015 Dec 1;4(12):e002015. doi: 10.1161/JAHA.115.002015. Erratum In: J Am Heart Assoc. 2021 Feb 16;10(4):e014653.
- Vinereanu D, Stevens SR, Alexander JH, Al-Khatib SM, Avezum A, Bahit MC, Granger CB, Lopes RD, Halvorsen S, Hanna M, Husted S, Hylek EM, Margulescu AD, Wallentin L, Atar D. Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial. Eur Heart J. 2015 Dec 7;36(46):3268-75. doi: 10.1093/eurheartj/ehv447. Epub 2015 Sep 14.
- Avezum A, Lopes RD, Schulte PJ, Lanas F, Gersh BJ, Hanna M, Pais P, Erol C, Diaz R, Bahit MC, Bartunek J, De Caterina R, Goto S, Ruzyllo W, Zhu J, Granger CB, Alexander JH. Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: Findings From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial. Circulation. 2015 Aug 25;132(8):624-32. doi: 10.1161/CIRCULATIONAHA.114.014807. Epub 2015 Jun 23.
- Held C, Hylek EM, Alexander JH, Hanna M, Lopes RD, Wojdyla DM, Thomas L, Al-Khalidi H, Alings M, Xavier D, Ansell J, Goto S, Ruzyllo W, Rosenqvist M, Verheugt FW, Zhu J, Granger CB, Wallentin L. Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial. Eur Heart J. 2015 May 21;36(20):1264-72. doi: 10.1093/eurheartj/ehu463. Epub 2014 Dec 12.
- Hijazi Z, Siegbahn A, Andersson U, Lindahl B, Granger CB, Alexander JH, Atar D, Gersh BJ, Hanna M, Harjola VP, Horowitz J, Husted S, Hylek EM, Lopes RD, McMurray JJ, Wallentin L. Comparison of cardiac troponins I and T measured with high-sensitivity methods for evaluation of prognosis in atrial fibrillation: an ARISTOTLE substudy. Clin Chem. 2015 Feb;61(2):368-78. doi: 10.1373/clinchem.2014.226936. Epub 2014 Dec 1.
- Garcia D, Alexander JH, Wallentin L, Wojdyla DM, Thomas L, Hanna M, Al-Khatib SM, Dorian P, Ansell J, Commerford P, Flaker G, Lanas F, Vinereanu D, Xavier D, Hylek EM, Held C, Verheugt FW, Granger CB, Lopes RD. Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures. Blood. 2014 Dec 11;124(25):3692-8. doi: 10.1182/blood-2014-08-595496. Epub 2014 Oct 15.
- Wallentin L, Hijazi Z, Andersson U, Alexander JH, De Caterina R, Hanna M, Horowitz JD, Hylek EM, Lopes RD, Asberg S, Granger CB, Siegbahn A; ARISTOTLE Investigators. Growth differentiation factor 15, a marker of oxidative stress and inflammation, for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. Circulation. 2014 Nov 18;130(21):1847-58. doi: 10.1161/CIRCULATIONAHA.114.011204. Epub 2014 Oct 7.
- Hijazi Z, Siegbahn A, Andersson U, Granger CB, Alexander JH, Atar D, Gersh BJ, Mohan P, Harjola VP, Horowitz J, Husted S, Hylek EM, Lopes RD, McMurray JJ, Wallentin L; ARISTOTLE Investigators. High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial. Circulation. 2014 Feb 11;129(6):625-34. doi: 10.1161/CIRCULATIONAHA.113.006286. Epub 2013 Nov 13.
- Flaker G, Lopes RD, Al-Khatib SM, Hermosillo AG, Hohnloser SH, Tinga B, Zhu J, Mohan P, Garcia D, Bartunek J, Vinereanu D, Husted S, Harjola VP, Rosenqvist M, Alexander JH, Granger CB; ARISTOTLE Committees and Investigators. Efficacy and safety of apixaban in patients after cardioversion for atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation). J Am Coll Cardiol. 2014 Mar 25;63(11):1082-7. doi: 10.1016/j.jacc.2013.09.062. Epub 2013 Nov 6.
- Hijazi Z, Wallentin L, Siegbahn A, Andersson U, Alexander JH, Atar D, Gersh BJ, Hanna M, Harjola VP, Horowitz JD, Husted S, Hylek EM, Lopes RD, McMurray JJ, Granger CB; ARISTOTLE Investigators. High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin. J Am Coll Cardiol. 2014 Jan 7-14;63(1):52-61. doi: 10.1016/j.jacc.2013.07.093. Epub 2013 Sep 19.
- Alexander JH, Levy E, Lawrence J, Hanna M, Waclawski AP, Wang J, Califf RM, Wallentin L, Granger CB. Documentation of study medication dispensing in a prospective large randomized clinical trial: experiences from the ARISTOTLE Trial. Am Heart J. 2013 Sep;166(3):559-65. doi: 10.1016/j.ahj.2013.05.025. Epub 2013 Aug 15.
- Garcia DA, Wallentin L, Lopes RD, Thomas L, Alexander JH, Hylek EM, Ansell J, Hanna M, Lanas F, Flaker G, Commerford P, Xavier D, Vinereanu D, Yang H, Granger CB. Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial. Am Heart J. 2013 Sep;166(3):549-58. doi: 10.1016/j.ahj.2013.05.016. Epub 2013 Jul 25.
- Wallentin L, Lopes RD, Hanna M, Thomas L, Hellkamp A, Nepal S, Hylek EM, Al-Khatib SM, Alexander JH, Alings M, Amerena J, Ansell J, Aylward P, Bartunek J, Commerford P, De Caterina R, Erol C, Harjola VP, Held C, Horowitz JD, Huber K, Husted S, Keltai M, Lanas F, Lisheng L, McMurray JJ, Oh BH, Rosenqvist M, Ruzyllo W, Steg PG, Vinereanu D, Xavier D, Granger CB; Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Investigators. Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation. Circulation. 2013 Jun 4;127(22):2166-76. doi: 10.1161/CIRCULATIONAHA.112.142158. Epub 2013 May 2.
- McMurray JJ, Ezekowitz JA, Lewis BS, Gersh BJ, van Diepen S, Amerena J, Bartunek J, Commerford P, Oh BH, Harjola VP, Al-Khatib SM, Hanna M, Alexander JH, Lopes RD, Wojdyla DM, Wallentin L, Granger CB; ARISTOTLE Committees and Investigators. Left ventricular systolic dysfunction, heart failure, and the risk of stroke and systemic embolism in patients with atrial fibrillation: insights from the ARISTOTLE trial. Circ Heart Fail. 2013 May;6(3):451-60. doi: 10.1161/CIRCHEARTFAILURE.112.000143. Epub 2013 Apr 10.
- Hijazi Z, Wallentin L, Siegbahn A, Andersson U, Christersson C, Ezekowitz J, Gersh BJ, Hanna M, Hohnloser S, Horowitz J, Huber K, Hylek EM, Lopes RD, McMurray JJ, Granger CB. N-terminal pro-B-type natriuretic peptide for risk assessment in patients with atrial fibrillation: insights from the ARISTOTLE Trial (Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation). J Am Coll Cardiol. 2013 Jun 4;61(22):2274-84. doi: 10.1016/j.jacc.2012.11.082. Epub 2013 Apr 3.
- Lopes RD, Al-Khatib SM, Wallentin L, Yang H, Ansell J, Bahit MC, De Caterina R, Dorian P, Easton JD, Erol C, Ezekowitz JA, Gersh BJ, Granger CB, Hohnloser SH, Horowitz J, Hylek EM, McMurray JJ, Mohan P, Vinereanu D, Alexander JH. Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial. Lancet. 2012 Nov 17;380(9855):1749-58. doi: 10.1016/S0140-6736(12)60986-6. Epub 2012 Oct 2. Erratum In: Lancet. 2013 Jan 19;381(9862):204.
- Easton JD, Lopes RD, Bahit MC, Wojdyla DM, Granger CB, Wallentin L, Alings M, Goto S, Lewis BS, Rosenqvist M, Hanna M, Mohan P, Alexander JH, Diener HC; ARISTOTLE Committees and Investigators. Apixaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of the ARISTOTLE trial. Lancet Neurol. 2012 Jun;11(6):503-11. doi: 10.1016/S1474-4422(12)70092-3. Epub 2012 May 8. Erratum In: Lancet Neurol. 2012 Dec;11(12):1021.
- Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L; ARISTOTLE Committees and Investigators. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011 Sep 15;365(11):981-92. doi: 10.1056/NEJMoa1107039. Epub 2011 Aug 27.
Полезные ссылки
Даты записи исследования
Эти даты отслеживают ход отправки отчетов об исследованиях и сводных результатов на сайт ClinicalTrials.gov. Записи исследований и сообщаемые результаты проверяются Национальной медицинской библиотекой (NLM), чтобы убедиться, что они соответствуют определенным стандартам контроля качества, прежде чем публиковать их на общедоступном веб-сайте.
Изучение основных дат
Начало исследования (Действительный)
31 декабря 2006 г.
Первичное завершение (Действительный)
25 мая 2011 г.
Завершение исследования (Действительный)
25 мая 2011 г.
Даты регистрации исследования
Первый отправленный
18 декабря 2006 г.
Впервые представлено, что соответствует критериям контроля качества
18 декабря 2006 г.
Первый опубликованный (Оценивать)
19 декабря 2006 г.
Обновления учебных записей
Последнее опубликованное обновление (Действительный)
3 июля 2018 г.
Последнее отправленное обновление, отвечающее критериям контроля качества
5 июня 2018 г.
Последняя проверка
1 мая 2018 г.
Дополнительная информация
Термины, связанные с этим исследованием
Дополнительные соответствующие термины MeSH
- Патологические процессы
- Сердечные заболевания
- Сердечно-сосудистые заболевания
- Аритмии, Сердечные
- Мерцательная аритмия
- Трепетание предсердий
- Молекулярные механизмы фармакологического действия
- Ингибиторы ферментов
- Ингибиторы протеазы
- Ингибиторы фактора Ха
- Антитромбины
- Ингибиторы сериновых протеиназ
- Антикоагулянты
- Апиксабан
- Варфарин
Другие идентификационные номера исследования
- CV185-030
Эта информация была получена непосредственно с веб-сайта clinicaltrials.gov без каких-либо изменений. Если у вас есть запросы на изменение, удаление или обновление сведений об исследовании, обращайтесь по адресу register@clinicaltrials.gov. Как только изменение будет реализовано на clinicaltrials.gov, оно будет автоматически обновлено и на нашем веб-сайте. .